,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2022-03-10 18:02:16,2022-03-08,INCY,Baker Bros. Advisors LP,"Dir, 10%",M - OptEx,$22.05,40000,34012428,0%,"+$882,000",,,,,INCY
1,DM,2022-03-10 18:02:16,2022-03-08,INCY,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$72.24,389080,34012428,+1%,"+$28,107,770",,,,,INCY
2,M,2022-02-22 17:45:07,2022-02-17,INCY,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$67.96,525804,33632977,+2%,"+$35,734,890",,,,,INCY
3,,2022-02-15 16:21:00,2022-02-11,INCY,Stamoulis Christiana,"EVP, CFO",F - Tax,$66.76,-1177,56285,-2%,"-$78,577",,,,,INCY
4,,2022-02-02 16:25:04,2022-01-31,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",S - Sale,$74.19,-7375,30214,-20%,"-$547,151",,,,,INCY
5,,2022-01-26 16:11:43,2022-01-24,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$75.34,-78,55610,0%,"-$5,877",,,,,INCY
6,,2022-01-26 16:09:51,2022-01-24,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$75.34,-78,37589,0%,"-$5,877",,,,,INCY
7,,2022-01-20 16:21:06,2022-01-19,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",A - Grant,$0.00,6959,55688,+14%,+$0,,,,,INCY
8,,2022-01-20 16:21:06,2022-01-18,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$75.01,-202,55688,0%,"-$15,152",,,,,INCY
9,,2022-01-20 16:18:38,2022-01-19,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",A - Grant,$0.00,6959,37667,+23%,+$0,,,,,INCY
10,,2022-01-20 16:18:38,2022-01-18,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$75.01,-202,37667,-1%,"-$15,152",,,,,INCY
11,D,2022-01-11 16:18:49,2022-01-07,INCY,Swain Paula J,"EVP, HR",M - OptEx,$73.21,10870,72371,+18%,"+$795,793",,,,,INCY
12,D,2022-01-11 16:18:49,2022-01-07,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$73.31,-10870,72371,-13%,"-$796,880",,,,,INCY
13,,2022-01-06 16:28:16,2022-01-04,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$71.81,-136,48931,0%,"-$9,766",,,,,INCY
14,,2022-01-06 16:26:40,2022-01-04,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$71.81,-136,30910,0%,"-$9,766",,,,,INCY
15,D,2022-01-05 16:40:31,2022-01-03,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$73.21,8214,32268,+34%,"+$601,347",,,,,INCY
16,D,2022-01-05 16:40:31,2022-01-03,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$73.31,-8214,32268,-20%,"-$602,168",,,,,INCY
17,D,2022-01-05 16:25:51,2022-01-01,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,8678,72371,+14%,+$0,,,,,INCY
18,D,2022-01-05 16:25:51,2022-01-04,INCY,Swain Paula J,"EVP, HR",M - OptEx,$73.21,9319,72371,+15%,"+$682,244",,,,,INCY
19,D,2022-01-05 16:25:51,2022-01-04,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$73.46,-9319,72371,-11%,"-$684,574",,,,,INCY
20,,2022-01-05 16:21:57,2022-01-01,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,28926,133823,+28%,+$0,,,,,INCY
21,,2022-01-05 16:19:01,2022-01-01,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$0.00,14463,57462,+34%,+$0,,,,,INCY
22,,2022-01-05 16:17:18,2022-01-01,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,14463,53575,+37%,+$0,,,,,INCY
23,,2022-01-05 16:13:47,2022-01-01,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",A - Grant,$0.00,3615,49067,+8%,+$0,,,,,INCY
24,,2022-01-05 16:12:15,2022-01-01,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,8678,38417,+29%,+$0,,,,,INCY
25,,2022-01-05 16:10:42,2022-01-01,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,8678,67292,+15%,+$0,,,,,INCY
26,,2022-01-05 16:08:45,2022-01-01,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",A - Grant,$0.00,3615,31046,+13%,+$0,,,,,INCY
27,,2022-01-05 16:06:56,2022-01-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,8678,42142,+26%,+$0,,,,,INCY
28,,2022-01-04 16:17:33,2021-12-31,INCY,Harrigan Edmund,Dir,A - Grant,$73.40,253,5332,+5%,"+$18,570",,,,,INCY
29,,2022-01-04 16:16:24,2021-12-31,INCY,Fouse Jacqualyn A,Dir,A - Grant,$73.40,289,8231,+4%,"+$21,213",,,,,INCY
30,,2022-01-04 16:16:22,2021-12-31,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,838,31526488,0%,+$0,,,,,INCY
31,,2022-01-04 16:15:24,2021-12-31,INCY,Dixon Wendy L,Dir,A - Grant,$73.40,260,17519,+2%,"+$19,084",,,,,INCY
32,,2022-01-04 16:14:08,2021-12-31,INCY,Clancy Paul J,Dir,A - Grant,$73.40,343,7964,+5%,"+$25,176",,,,,INCY
33,D,2021-12-27 16:11:15,2021-12-23,INCY,Dixon Wendy L,Dir,M - OptEx,$73.25,20000,17259,-730%,"+$1,465,000",,,,,INCY
34,D,2021-12-27 16:11:15,2021-12-23,INCY,Dixon Wendy L,Dir,S - Sale+OE,$22.05,-20000,17259,-54%,"-$441,000",,,,,INCY
35,M,2021-12-17 18:30:00,2021-12-15,INCY,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$72.43,1595519,34399479,+5%,"+$115,558,900",,,,,INCY
36,,2021-12-14 16:23:25,2021-12-10,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",F - Tax,$65.40,-533,33464,-2%,"-$34,858",,,,,INCY
37,,2021-11-23 16:29:14,2021-11-19,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,2734,63693,+4%,+$0,,,,,INCY
38,,2021-11-23 16:27:15,2021-11-19,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,2734,104897,+3%,+$0,,,,,INCY
39,,2021-11-23 16:22:29,2021-11-19,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$0.00,2734,42999,+7%,+$0,,,,,INCY
40,,2021-11-23 16:18:20,2021-11-19,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,2734,39112,+8%,+$0,,,,,INCY
41,,2021-11-23 16:16:26,2021-11-19,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,2734,29739,+10%,+$0,,,,,INCY
42,,2021-11-23 16:14:39,2021-11-19,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,15506,392584,+4%,+$0,,,,,INCY
43,,2021-11-23 16:12:26,2021-11-19,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,2734,58614,+5%,+$0,,,,,INCY
44,,2021-11-23 16:07:21,2021-11-19,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,2734,33997,+9%,+$0,,,,,INCY
45,,2021-10-04 16:41:25,2021-10-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$68.67,-389,31263,-1%,"-$26,713",,,,,INCY
46,,2021-10-04 16:36:09,2021-09-30,INCY,Harrigan Edmund,Dir,A - Grant,$68.78,237,5079,+5%,"+$16,301",,,,,INCY
47,,2021-10-04 16:32:44,2021-09-30,INCY,Fouse Jacqualyn A,Dir,A - Grant,$68.78,271,7942,+4%,"+$18,639",,,,,INCY
48,,2021-10-04 16:28:51,2021-09-30,INCY,Dixon Wendy L,Dir,A - Grant,$68.78,244,17259,+1%,"+$16,782",,,,,INCY
49,,2021-10-04 16:26:03,2021-09-30,INCY,Clancy Paul J,Dir,A - Grant,$68.78,321,7621,+4%,"+$22,078",,,,,INCY
50,,2021-10-04 16:01:54,2021-09-30,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,786,29930550,0%,+$0,,,,,INCY
51,D,2021-09-29 18:19:29,2021-09-27,INCY,Brawley Otis W,Dir,A - Grant,$0.00,1255,1255,New,+$0,,,,,INCY
52,D,2021-09-28 08:18:12,2021-09-24,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,382,36187,+1%,"+$24,968",,,,,INCY
53,D,2021-09-21 16:09:48,2021-09-20,INCY,Swain Paula J,"EVP, HR",M - OptEx,$73.21,1356,60959,+2%,"+$99,273",,,,,INCY
54,,2021-09-03 07:40:32,2021-09-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$76.71,-388,31652,-1%,"-$29,763",,,,,INCY
55,,2021-08-04 16:16:19,2021-08-02,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$77.49,-389,32040,-1%,"-$30,144",,,,,INCY
56,,2021-08-02 16:14:20,2021-07-29,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$78.29,-4911,27005,-15%,"-$384,482",,,,,INCY
57,D,2021-07-07 18:39:10,2021-07-02,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,4521,32268,+16%,+$0,,,,,INCY
58,DM,2021-07-07 18:39:10,2021-07-02,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$83.55,-976,32268,-3%,"-$81,549",,,,,INCY
59,D,2021-07-07 17:54:42,2021-07-02,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,7853,98575,+9%,+$0,,,,,INCY
60,DM,2021-07-07 17:54:42,2021-07-02,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$83.55,-3358,98575,-3%,"-$280,564",,,,,INCY
61,D,2021-07-07 17:43:33,2021-07-02,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,7853,102163,+8%,+$0,,,,,INCY
62,DM,2021-07-07 17:43:33,2021-07-02,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$83.55,-3355,102163,-3%,"-$280,314",,,,,INCY
63,D,2021-07-07 16:44:59,2021-07-02,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,7853,59603,+15%,+$0,,,,,INCY
64,DM,2021-07-07 16:44:59,2021-07-02,INCY,Swain Paula J,"EVP, HR",F - Tax,$83.55,-2263,59603,-4%,"-$189,076",,,,,INCY
65,D,2021-07-07 16:39:29,2021-07-02,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$0.00,7853,40265,+24%,+$0,,,,,INCY
66,D,2021-07-07 16:39:29,2021-07-02,INCY,Stamoulis Christiana,"EVP, CFO",F - Tax,$0.00,-516,40265,-1%,-$0,,,,,INCY
67,D,2021-07-07 16:34:17,2021-07-02,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,7853,35805,+28%,+$0,,,,,INCY
68,D,2021-07-07 16:34:17,2021-07-02,INCY,Pasquale Maria E,"EVP, GC",F - Tax,$83.58,-2241,35805,-6%,"-$187,303",,,,,INCY
69,D,2021-07-07 16:28:49,2021-07-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,7853,31916,+33%,+$0,,,,,INCY
70,DM,2021-07-07 16:28:49,2021-07-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",F - Tax,$83.54,-2391,31916,-7%,"-$199,744",,,,,INCY
71,D,2021-07-07 16:23:00,2021-07-02,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,44264,471480,+10%,+$0,,,,,INCY
72,DM,2021-07-07 16:23:00,2021-07-02,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$83.56,-17651,471480,-4%,"-$1,474,896",,,,,INCY
73,D,2021-07-07 16:14:34,2021-07-02,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,7853,55880,+16%,+$0,,,,,INCY
74,DM,2021-07-07 16:14:34,2021-07-02,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$83.55,-2263,55880,-4%,"-$189,076",,,,,INCY
75,D,2021-07-07 16:09:28,2021-07-02,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,7853,32429,+32%,+$0,,,,,INCY
76,D,2021-07-07 16:09:28,2021-07-02,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",F - Tax,$83.58,-1573,32429,-5%,"-$131,471",,,,,INCY
77,,2021-07-02 19:15:24,2021-07-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$84.09,-396,26149,-1%,"-$33,300",,,,,INCY
78,,2021-07-02 16:04:16,2021-06-30,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,690,29930157,0%,+$0,,,,,INCY
79,,2021-07-02 07:32:14,2021-06-30,INCY,Harrigan Edmund,Dir,A - Grant,$84.13,208,4842,+4%,"+$17,499",,,,,INCY
80,,2021-07-02 07:23:07,2021-06-30,INCY,Dixon Wendy L,Dir,A - Grant,$84.13,214,17015,+1%,"+$18,004",,,,,INCY
81,,2021-07-02 07:19:46,2021-06-30,INCY,Fouse Jacqualyn A,Dir,A - Grant,$84.13,238,7671,+3%,"+$20,023",,,,,INCY
82,,2021-07-02 07:16:16,2021-06-30,INCY,Clancy Paul J,Dir,A - Grant,$84.13,283,7300,+4%,"+$23,809",,,,,INCY
83,,2021-06-30 16:14:50,2021-06-28,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$85.61,-22079,97665,-18%,"-$1,890,183",,,,,INCY
84,,2021-06-30 16:11:22,2021-06-28,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$85.61,-22806,94080,-20%,"-$1,952,422",,,,,INCY
85,,2021-06-30 16:11:22,2021-06-29,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale,$85.37,-27194,94080,-22%,"-$2,321,552",,,,,INCY
86,D,2021-06-22 16:04:29,2021-06-18,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,255,30193,+1%,"+$16,667",,,,,INCY
87,D,2021-06-14 16:28:17,2021-06-10,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,3845,26545,+17%,"+$251,540",,,,,INCY
88,D,2021-06-14 16:28:17,2021-06-10,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$87.00,-3845,26545,-13%,"-$334,515",,,,,INCY
89,,2021-06-03 16:42:35,2021-06-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$84.13,-395,26545,-1%,"-$33,231",,,,,INCY
90,D,2021-05-28 16:17:23,2021-05-26,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,3846,29929812,0%,+$0,,,,,INCY
91,D,2021-05-28 07:17:26,2021-05-26,INCY,High Katherine A,Dir,A - Grant,$0.00,1923,3344,+135%,+$0,,,,,INCY
92,D,2021-05-28 07:14:42,2021-05-26,INCY,Harrigan Edmund,Dir,A - Grant,$0.00,1923,4634,+71%,+$0,,,,,INCY
93,D,2021-05-28 07:10:36,2021-05-26,INCY,Fouse Jacqualyn A,Dir,A - Grant,$0.00,1923,7433,+35%,+$0,,,,,INCY
94,D,2021-05-28 07:06:45,2021-05-26,INCY,Dixon Wendy L,Dir,A - Grant,$0.00,1923,16801,+13%,+$0,,,,,INCY
95,D,2021-05-28 07:01:52,2021-05-26,INCY,Clancy Paul J,Dir,A - Grant,$0.00,1923,7017,+38%,+$0,,,,,INCY
96,D,2021-05-28 06:57:37,2021-05-26,INCY,Bienaime Jean Jacques,Dir,A - Grant,$0.00,1923,10844,+22%,+$0,,,,,INCY
97,D,2021-05-18 16:25:08,2021-05-14,INCY,Baker Bros. Advisors LP,"Dir, 10%",M - OptEx,$18.97,40000,29927889,0%,"+$758,800",,,,,INCY
98,,2021-05-05 16:09:04,2021-05-03,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$85.40,-396,26940,-1%,"-$33,818",,,,,INCY
99,D,2021-04-27 16:57:14,2021-04-23,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,29938,0%,"+$8,301",,,,,INCY
100,,2021-04-13 16:14:47,2021-04-09,INCY,Pasquale Maria E,"EVP, GC",F - Tax,$79.96,-517,29811,-2%,"-$41,339",,,,,INCY
101,,2021-04-05 16:25:39,2021-04-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$81.57,-396,27336,-1%,"-$32,302",,,,,INCY
102,,2021-04-01 17:53:43,2021-03-31,INCY,Fouse Jacqualyn A,Dir,A - Grant,$81.27,251,5510,+5%,"+$20,399",,,,,INCY
103,,2021-04-01 17:20:13,2021-03-31,INCY,Harrigan Edmund,Dir,A - Grant,$81.27,219,2711,+9%,"+$17,798",,,,,INCY
104,,2021-04-01 17:09:25,2021-03-31,INCY,Dixon Wendy L,Dir,A - Grant,$81.27,225,14878,+2%,"+$18,286",,,,,INCY
105,,2021-04-01 17:07:03,2021-03-31,INCY,Clancy Paul J,Dir,A - Grant,$81.27,298,5094,+6%,"+$24,218",,,,,INCY
106,,2021-04-01 16:29:55,2021-03-31,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,728,29907889,0%,+$0,,,,,INCY
107,,2021-03-31 16:10:24,2021-03-29,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",S - Sale,$81.08,-20000,45452,-31%,"-$1,621,600",,,,,INCY
108,D,2021-03-16 16:17:11,2021-03-12,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,128,30328,0%,"+$8,366",,,,,INCY
109,,2021-03-03 16:28:10,2021-03-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale,$79.73,-395,27732,-1%,"-$31,493",,,,,INCY
110,,2021-02-23 16:54:13,2021-02-23,INCY,Hoppenot Herve,"COB , CEO",P - Purchase,$77.37,12925,350465,+4%,"+$1,000,007",,,,,INCY
111,D,2021-02-18 16:38:49,2021-02-16,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,30200,0%,"+$8,301",,,,,INCY
112,,2021-02-16 16:40:04,2021-02-11,INCY,Stamoulis Christiana,"EVP, CFO",F - Tax,$84.99,-1210,32611,-4%,"-$102,838",,,,,INCY
113,D,2021-02-03 16:27:38,2021-02-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,28127,+4%,"+$62,869",,,,,INCY
114,D,2021-02-03 16:27:38,2021-02-01,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$90.00,-1356,28127,-5%,"-$122,040",,,,,INCY
115,D,2021-01-27 17:32:18,2021-01-25,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$73.21,21545,143784,+18%,"+$1,577,309",,,,,INCY
116,D,2021-01-27 17:32:18,2021-01-25,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$100.00,-21545,143784,-13%,"-$2,154,500",,,,,INCY
117,D,2021-01-27 17:09:06,2021-01-25,INCY,Stein Steven H,"EVP, Chief Medical Officer",M - OptEx,$68.62,3795,119744,+3%,"+$260,413",,,,,INCY
118,D,2021-01-27 17:09:06,2021-01-25,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$100.00,-3795,119744,-3%,"-$379,500",,,,,INCY
119,D,2021-01-27 17:03:16,2021-01-25,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",M - OptEx,$72.86,4116,26158,+19%,"+$299,892",,,,,INCY
120,D,2021-01-27 17:03:16,2021-01-25,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$99.00,-5116,26158,-16%,"-$506,484",,,,,INCY
121,,2021-01-27 16:52:09,2021-01-25,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$100.00,-2744,49994,-5%,"-$274,400",,,,,INCY
122,,2021-01-27 16:46:15,2021-01-25,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$100.50,-78,65452,0%,"-$7,839",,,,,INCY
123,,2021-01-27 16:43:25,2021-01-25,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$100.50,-78,27135,0%,"-$7,839",,,,,INCY
124,D,2021-01-20 18:02:13,2021-01-15,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$0.00,11522,33821,+52%,+$0,,,,,INCY
125,D,2021-01-20 17:40:52,2021-01-15,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,11522,143784,+9%,+$0,,,,,INCY
126,D,2021-01-20 17:14:47,2021-01-15,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,23044,119744,+24%,+$0,,,,,INCY
127,D,2021-01-20 17:07:06,2021-01-15,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,11522,52738,+28%,+$0,,,,,INCY
128,,2021-01-20 17:02:09,2021-01-15,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",A - Grant,$0.00,17283,65530,+36%,+$0,,,,,INCY
129,,2021-01-20 17:02:09,2021-01-19,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$93.96,-174,65530,0%,"-$16,349",,,,,INCY
130,D,2021-01-20 16:51:24,2021-01-15,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,4032,28427,+17%,+$0,,,,,INCY
131,,2021-01-20 16:44:50,2021-01-15,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",A - Grant,$0.00,5761,27213,+27%,+$0,,,,,INCY
132,,2021-01-20 16:44:50,2021-01-19,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$93.96,-174,27213,-1%,"-$16,349",,,,,INCY
133,D,2021-01-13 16:15:20,2021-01-11,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,30073,0%,"+$8,301",,,,,INCY
134,,2021-01-06 16:34:03,2021-01-04,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$86.45,-136,48421,0%,"-$11,757",,,,,INCY
135,,2021-01-06 16:26:42,2021-01-04,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$86.45,-136,21626,-1%,"-$11,757",,,,,INCY
136,,2021-01-05 18:31:36,2020-12-31,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,686,29907525,0%,+$0,,,,,INCY
137,,2021-01-05 17:00:40,2020-12-31,INCY,Harrigan Edmund,Dir,A - Grant,$86.98,207,2492,+9%,"+$18,005",,,,,INCY
138,,2021-01-05 16:55:28,2020-12-31,INCY,Clancy Paul J,Dir,A - Grant,$86.98,281,4796,+6%,"+$24,441",,,,,INCY
139,,2021-01-05 16:51:51,2020-12-31,INCY,Fouse Jacqualyn A,Dir,A - Grant,$86.98,237,5259,+5%,"+$20,614",,,,,INCY
140,,2021-01-05 16:48:35,2020-12-31,INCY,Bienaime Jean Jacques,Dir,A - Grant,$86.98,275,8921,+3%,"+$23,920",,,,,INCY
141,,2021-01-05 16:45:27,2020-12-31,INCY,Dixon Wendy L,Dir,A - Grant,$86.98,213,14653,+1%,"+$18,527",,,,,INCY
142,D,2020-12-15 16:51:04,2020-12-11,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,128,29946,0%,"+$8,366",,,,,INCY
143,,2020-12-14 16:19:05,2020-12-10,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",F - Tax,$82.05,-720,28522,-2%,"-$59,076",,,,,INCY
144,,2020-11-18 17:03:45,2020-11-16,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,1232,156851,+1%,+$0,,,,,INCY
145,,2020-11-18 16:58:34,2020-11-16,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,1232,54013,+2%,+$0,,,,,INCY
146,,2020-11-18 16:55:41,2020-11-16,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,1232,96700,+1%,+$0,,,,,INCY
147,,2020-11-18 16:46:46,2020-11-16,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$0.00,1232,22299,+6%,+$0,,,,,INCY
148,,2020-11-18 16:38:15,2020-11-16,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,1232,29818,+4%,+$0,,,,,INCY
149,,2020-11-18 16:35:20,2020-11-16,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,1232,27158,+5%,+$0,,,,,INCY
150,,2020-11-18 16:30:36,2020-11-16,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,7225,337540,+2%,+$0,,,,,INCY
151,,2020-11-18 16:20:41,2020-11-16,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,1232,41216,+3%,+$0,,,,,INCY
152,,2020-11-18 16:16:28,2020-11-16,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,1232,29242,+4%,+$0,,,,,INCY
153,D,2020-11-16 16:56:00,2020-11-12,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,28586,0%,"+$8,301",,,,,INCY
154,,2020-11-12 16:41:38,2020-11-10,INCY,Bienaime Jean Jacques,Dir,S - Sale,$83.00,-798,8646,-8%,"-$66,234",,,,,INCY
155,D,2020-11-10 16:26:54,2020-11-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,28010,+4%,"+$62,869",,,,,INCY
156,D,2020-11-10 16:26:54,2020-11-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$85.17,-961,28010,-3%,"-$81,848",,,,,INCY
157,D,2020-11-04 16:15:40,2020-11-02,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$48.44,20000,39984,+100%,"+$968,800",,,,,INCY
158,D,2020-11-04 16:15:40,2020-11-02,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$86.60,-20000,39984,-33%,"-$1,732,000",,,,,INCY
159,DM,2020-10-13 17:10:55,2020-10-09,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$68.35,1551,28459,+6%,"+$106,012",,,,,INCY
160,D,2020-10-13 17:10:55,2020-10-09,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$95.00,-1423,28459,-5%,"-$135,185",,,,,INCY
161,D,2020-10-08 16:21:45,2020-10-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,28010,+4%,"+$62,869",,,,,INCY
162,D,2020-10-08 16:21:45,2020-10-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$91.97,-961,28010,-3%,"-$88,383",,,,,INCY
163,,2020-10-02 18:15:08,2020-09-30,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,634,29907182,0%,+$0,,,,,INCY
164,,2020-10-01 16:52:03,2020-09-30,INCY,Harrigan Edmund,Dir,A - Grant,$89.74,187,2285,+9%,"+$16,781",,,,,INCY
165,,2020-10-01 16:48:44,2020-09-30,INCY,Fouse Jacqualyn A,Dir,A - Grant,$89.74,219,5022,+5%,"+$19,653",,,,,INCY
166,,2020-10-01 16:46:30,2020-09-30,INCY,Dixon Wendy L,Dir,A - Grant,$89.74,197,14440,+1%,"+$17,679",,,,,INCY
167,,2020-10-01 16:43:05,2020-09-30,INCY,Clancy Paul J,Dir,A - Grant,$89.74,260,4515,+6%,"+$23,332",,,,,INCY
168,,2020-10-01 16:40:36,2020-09-30,INCY,Bienaime Jean Jacques,Dir,A - Grant,$89.74,254,9444,+3%,"+$22,794",,,,,INCY
169,DM,2020-09-14 16:19:44,2020-09-10,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,2320,28331,+9%,"+$151,635",,,,,INCY
170,D,2020-09-14 16:19:44,2020-09-10,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$90.83,-2193,28331,-7%,"-$199,190",,,,,INCY
171,D,2020-09-10 16:21:35,2020-09-08,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,28010,+4%,"+$62,869",,,,,INCY
172,D,2020-09-10 16:21:35,2020-09-08,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$88.94,-961,28010,-3%,"-$85,471",,,,,INCY
173,D,2020-08-31 16:26:17,2020-08-27,INCY,Dixon Wendy L,Dir,M - OptEx,$18.97,20000,14243,-347%,"+$379,400",,,,,INCY
174,D,2020-08-31 16:26:17,2020-08-27,INCY,Dixon Wendy L,Dir,S - Sale+OE,$94.51,-20000,14243,-58%,"-$1,890,200",,,,,INCY
175,D,2020-08-12 16:08:48,2020-08-10,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,128,28204,0%,"+$8,366",,,,,INCY
176,D,2020-08-10 16:20:57,2020-08-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,28010,+4%,"+$62,869",,,,,INCY
177,D,2020-08-10 16:20:57,2020-08-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$97.80,-961,28010,-3%,"-$93,986",,,,,INCY
178,,2020-07-17 16:31:25,2020-07-15,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$104.25,-639,155619,0%,"-$66,616",,,,,INCY
179,,2020-07-17 16:25:08,2020-07-15,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$104.25,-203,24395,-1%,"-$21,163",,,,,INCY
180,,2020-07-17 16:22:54,2020-07-15,INCY,Swain Paula J,"EVP, HR",F - Tax,$104.25,-626,52781,-1%,"-$65,261",,,,,INCY
181,,2020-07-17 16:20:57,2020-07-15,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$104.25,-623,95468,-1%,"-$64,948",,,,,INCY
182,,2020-07-17 16:20:57,2020-07-16,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale,$103.83,-766,95468,-1%,"-$79,534",,,,,INCY
183,,2020-07-17 16:11:38,2020-07-15,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$104.25,-2420,330315,-1%,"-$252,285",,,,,INCY
184,,2020-07-17 16:08:48,2020-07-15,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$104.25,-639,39903,-2%,"-$66,616",,,,,INCY
185,D,2020-07-14 16:39:43,2020-07-10,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,28076,0%,"+$8,301",,,,,INCY
186,D,2020-07-14 16:31:43,2020-07-13,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,2419,28010,+9%,"+$158,251",,,,,INCY
187,M,2020-07-08 17:31:17,2020-07-07,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$108.06,-3595,25926,-12%,"-$388,464",,,,,INCY
188,D,2020-07-08 17:27:32,2020-07-07,INCY,Stein Steven H,"EVP, Chief Medical Officer",M - OptEx,$88.68,10876,96857,+13%,"+$964,484",,,,,INCY
189,DM,2020-07-08 17:27:32,2020-07-07,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$109.52,-14769,96857,-13%,"-$1,617,548",,,,,INCY
190,D,2020-07-07 19:30:07,2020-07-02,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,6661,156258,+4%,+$0,,,,,INCY
191,DM,2020-07-07 19:30:07,2020-07-02,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$106.68,-2591,156258,-2%,"-$276,397",,,,,INCY
192,D,2020-07-07 19:30:07,2020-07-06,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$64.55,16553,156258,+12%,"+$1,068,496",,,,,INCY
193,D,2020-07-07 19:30:07,2020-07-06,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$107.32,-16553,156258,-10%,"-$1,776,468",,,,,INCY
194,D,2020-07-07 19:29:01,2020-07-02,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,3532,24598,+17%,+$0,,,,,INCY
195,DM,2020-07-07 19:29:01,2020-07-02,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$106.68,-668,24598,-3%,"-$71,259",,,,,INCY
196,D,2020-07-07 19:27:59,2020-07-02,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,6661,53407,+14%,+$0,,,,,INCY
197,DM,2020-07-07 19:27:59,2020-07-02,INCY,Swain Paula J,"EVP, HR",F - Tax,$106.70,-1747,53407,-3%,"-$186,413",,,,,INCY
198,D,2020-07-07 19:25:52,2020-07-02,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,6661,100750,+7%,+$0,,,,,INCY
199,DM,2020-07-07 19:25:52,2020-07-02,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$106.67,-1743,100750,-2%,"-$185,932",,,,,INCY
200,D,2020-07-07 19:25:52,2020-07-06,INCY,Stein Steven H,"EVP, Chief Medical Officer",M - OptEx,$75.52,33602,100750,+50%,"+$2,537,457",,,,,INCY
201,D,2020-07-07 19:25:52,2020-07-06,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$107.25,-36124,100750,-26%,"-$3,874,171",,,,,INCY
202,D,2020-07-07 19:24:15,2020-07-02,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$0.00,6661,21067,+46%,+$0,,,,,INCY
203,D,2020-07-07 19:22:28,2020-07-02,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,6661,27949,+31%,+$0,,,,,INCY
204,D,2020-07-07 19:22:28,2020-07-02,INCY,Pasquale Maria E,"EVP, GC",F - Tax,$106.47,-2373,27949,-8%,"-$252,653",,,,,INCY
205,D,2020-07-07 19:20:12,2020-07-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,6661,29521,+29%,+$0,,,,,INCY
206,DM,2020-07-07 19:20:12,2020-07-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",F - Tax,$106.73,-2041,29521,-6%,"-$217,839",,,,,INCY
207,D,2020-07-07 19:18:12,2020-07-02,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,39059,730139,+6%,+$0,,,,,INCY
208,DM,2020-07-07 19:18:12,2020-07-02,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$106.63,-13161,730139,-2%,"-$1,403,310",,,,,INCY
209,D,2020-07-07 19:18:12,2020-07-07,INCY,Hoppenot Herve,"COB , CEO",M - OptEx,$73.21,89771,730139,+14%,"+$6,572,135",,,,,INCY
210,D,2020-07-07 19:18:12,2020-07-07,INCY,Hoppenot Herve,"COB , CEO",S - Sale+OE,$110.00,-89771,730139,-11%,"-$9,874,810",,,,,INCY
211,D,2020-07-07 19:15:23,2020-07-02,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,6661,40542,+20%,+$0,,,,,INCY
212,DM,2020-07-07 19:15:23,2020-07-02,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$106.72,-2180,40542,-5%,"-$232,638",,,,,INCY
213,D,2020-07-07 19:13:36,2020-07-02,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,6661,25591,+35%,+$0,,,,,INCY
214,D,2020-07-07 19:13:36,2020-07-02,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",F - Tax,$106.47,-1057,25591,-4%,"-$112,539",,,,,INCY
215,D,2020-07-07 19:13:36,2020-07-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,25591,+4%,"+$62,869",,,,,INCY
216,D,2020-07-07 19:13:36,2020-07-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$106.58,-961,25591,-4%,"-$102,423",,,,,INCY
217,,2020-07-02 17:54:00,2020-06-30,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,588,29906865,0%,+$0,,,,,INCY
218,,2020-07-01 18:02:05,2020-06-30,INCY,Fouse Jacqualyn A,Dir,A - Grant,$103.97,202,4803,+4%,"+$21,002",,,,,INCY
219,,2020-07-01 17:09:34,2020-06-30,INCY,Harrigan Edmund,Dir,A - Grant,$103.97,152,2098,+8%,"+$15,803",,,,,INCY
220,,2020-07-01 16:57:09,2020-06-30,INCY,Dixon Wendy L,Dir,A - Grant,$103.97,182,14243,+1%,"+$18,923",,,,,INCY
221,,2020-07-01 16:51:31,2020-06-30,INCY,Clancy Paul J,Dir,A - Grant,$103.97,229,4255,+6%,"+$23,809",,,,,INCY
222,,2020-07-01 16:45:21,2020-06-30,INCY,Bienaime Jean Jacques,Dir,A - Grant,$103.97,208,9190,+2%,"+$21,626",,,,,INCY
223,D,2020-06-30 16:06:21,2020-06-26,INCY,Hoppenot Herve,"COB , CEO",M - OptEx,$64.55,124148,505539,+33%,"+$8,013,753",,,,,INCY
224,D,2020-06-30 16:06:21,2020-06-26,INCY,Hoppenot Herve,"COB , CEO",S - Sale+OE,$102.91,-124148,505539,-20%,"-$12,776,071",,,,,INCY
225,D,2020-06-25 17:15:52,2020-06-23,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$64.55,6943,21734,+47%,"+$448,171",,,,,INCY
226,D,2020-06-25 17:15:52,2020-06-23,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$110.00,-6943,21734,-24%,"-$763,730",,,,,INCY
227,D,2020-06-25 17:09:56,2020-06-23,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$73.21,599,36061,+2%,"+$43,853",,,,,INCY
228,D,2020-06-25 17:09:56,2020-06-23,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$110.00,-400,36061,-1%,"-$44,000",,,,,INCY
229,D,2020-06-23 16:42:06,2020-06-19,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$72.27,1423,23661,+6%,"+$102,840",,,,,INCY
230,D,2020-06-23 16:42:06,2020-06-19,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$100.00,-1423,23661,-6%,"-$142,300",,,,,INCY
231,D,2020-06-23 16:33:11,2020-06-19,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",M - OptEx,$72.86,7866,24901,+46%,"+$573,117",,,,,INCY
232,D,2020-06-23 16:33:11,2020-06-19,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$105.00,-7866,24901,-24%,"-$825,930",,,,,INCY
233,D,2020-06-23 16:23:03,2020-06-19,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$73.21,7181,35862,+25%,"+$525,721",,,,,INCY
234,D,2020-06-23 16:23:03,2020-06-19,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$105.00,-7181,35862,-17%,"-$754,005",,,,,INCY
235,,2020-06-23 16:17:21,2020-06-22,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",S - Sale,$105.31,-9000,21762,-29%,"-$947,790",,,,,INCY
236,,2020-06-22 16:29:48,2020-06-18,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,25000,152188,+20%,+$0,,,,,INCY
237,,2020-06-22 16:23:34,2020-06-18,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,25000,98354,+34%,+$0,,,,,INCY
238,D,2020-06-16 16:24:59,2020-06-12,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,23661,+1%,"+$8,301",,,,,INCY
239,D,2020-06-12 16:11:15,2020-06-10,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$66.64,3615,23534,+18%,"+$240,915",,,,,INCY
240,D,2020-06-12 16:11:15,2020-06-10,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$94.51,-3615,23534,-13%,"-$341,649",,,,,INCY
241,D,2020-06-10 16:34:48,2020-06-08,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,19987,+5%,"+$62,869",,,,,INCY
242,D,2020-06-10 16:34:48,2020-06-08,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$91.87,-961,19987,-5%,"-$88,287",,,,,INCY
243,D,2020-05-28 20:07:51,2020-05-26,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,2564,29906571,0%,+$0,,,,,INCY
244,D,2020-05-28 20:07:51,2020-05-28,INCY,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$102.55,2,29906571,0%,+$205,,,,,INCY
245,D,2020-05-28 16:36:34,2020-05-26,INCY,High Katherine A,Dir,A - Grant,$0.00,1282,1421,+922%,+$0,,,,,INCY
246,D,2020-05-28 16:32:03,2020-05-26,INCY,Harrigan Edmund,Dir,A - Grant,$0.00,1282,1946,+193%,+$0,,,,,INCY
247,D,2020-05-28 16:27:11,2020-05-26,INCY,Friedman Paul A,Dir,A - Grant,$0.00,1282,271813,0%,+$0,,,,,INCY
248,D,2020-05-28 16:18:29,2020-05-26,INCY,Fouse Jacqualyn A,Dir,A - Grant,$0.00,1282,4601,+39%,+$0,,,,,INCY
249,D,2020-05-28 16:15:43,2020-05-26,INCY,Dixon Wendy L,Dir,A - Grant,$0.00,1282,14061,+10%,+$0,,,,,INCY
250,D,2020-05-28 16:13:20,2020-05-26,INCY,Clancy Paul J,Dir,A - Grant,$0.00,1282,4026,+47%,+$0,,,,,INCY
251,D,2020-05-28 16:08:05,2020-05-26,INCY,Bienaime Jean Jacques,Dir,A - Grant,$0.00,1282,8982,+17%,+$0,,,,,INCY
252,D,2020-05-13 16:38:24,2020-05-11,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,128,23534,+1%,"+$8,366",,,,,INCY
253,D,2020-05-08 16:53:04,2020-05-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,961,19987,+5%,"+$62,869",,,,,INCY
254,D,2020-05-08 16:53:04,2020-05-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$96.84,-961,19987,-5%,"-$93,063",,,,,INCY
255,D,2020-04-29 16:45:06,2020-04-28,INCY,Baker Bros. Advisors LP,"Dir, 10%",M - OptEx,$13.34,40000,29905288,0%,"+$533,600",,,,,INCY
256,D,2020-04-21 16:35:38,2020-04-17,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$64.55,1143,21324,+6%,"+$73,781",,,,,INCY
257,D,2020-04-21 16:35:38,2020-04-17,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$100.00,-1143,21324,-5%,"-$114,300",,,,,INCY
258,D,2020-04-21 16:28:55,2020-04-17,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$73.21,6583,35342,+23%,"+$481,941",,,,,INCY
259,D,2020-04-21 16:28:55,2020-04-17,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$100.00,-6583,35342,-16%,"-$658,300",,,,,INCY
260,DM,2020-04-20 17:08:00,2020-04-16,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$70.45,18976,22899,+484%,"+$1,336,764",,,,,INCY
261,DM,2020-04-20 17:08:00,2020-04-16,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$97.50,-18976,22899,-45%,"-$1,850,160",,,,,INCY
262,DM,2020-04-15 16:57:36,2020-04-13,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,17954,22899,+363%,"+$1,173,473",,,,,INCY
263,DM,2020-04-15 16:57:36,2020-04-13,INCY,Pasquale Maria E,"EVP, GC",S - Sale+OE,$89.78,-18792,22899,-45%,"-$1,687,111",,,,,INCY
264,,2020-04-10 16:26:01,2020-04-09,INCY,Pasquale Maria E,"EVP, GC",F - Tax,$86.81,-517,23737,-2%,"-$44,881",,,,,INCY
265,,2020-04-08 16:39:41,2020-04-06,INCY,Pasquale Maria E,"EVP, GC",S - Sale,$85.00,-1842,24254,-7%,"-$156,570",,,,,INCY
266,D,2020-04-08 16:35:27,2020-04-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",M - OptEx,$65.42,3844,19987,+24%,"+$251,474",,,,,INCY
267,D,2020-04-08 16:35:27,2020-04-06,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",S - Sale+OE,$85.00,-3844,19987,-16%,"-$326,740",,,,,INCY
268,,2020-04-02 18:07:55,2020-03-31,INCY,Harrigan Edmund,Dir,A - Grant,$73.23,202,664,+44%,"+$14,792",,,,,INCY
269,D,2020-04-02 17:32:54,2020-03-31,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2329,48493,+5%,"+$150,337",,,,,INCY
270,D,2020-04-02 17:32:54,2020-03-31,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$71.44,-2329,48493,-5%,"-$166,384",,,,,INCY
271,,2020-04-02 17:18:10,2020-03-31,INCY,Fouse Jacqualyn A,Dir,A - Grant,$73.23,270,3319,+9%,"+$19,772",,,,,INCY
272,,2020-04-02 17:07:42,2020-03-31,INCY,Dixon Wendy L,Dir,A - Grant,$73.23,243,12779,+2%,"+$17,795",,,,,INCY
273,,2020-04-02 17:04:11,2020-03-31,INCY,Clancy Paul J,Dir,A - Grant,$73.23,287,2744,+12%,"+$21,017",,,,,INCY
274,,2020-04-02 17:01:14,2020-03-31,INCY,Brooke Paul A,Dir,A - Grant,$73.23,327,261911,0%,"+$23,946",,,,,INCY
275,,2020-04-02 16:55:23,2020-03-31,INCY,Bienaime Jean Jacques,Dir,A - Grant,$73.23,236,7700,+3%,"+$17,282",,,,,INCY
276,,2020-04-01 19:36:15,2020-03-31,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$73.23,784,29885288,0%,"+$57,412",,,,,INCY
277,D,2020-03-30 17:06:26,2020-03-26,INCY,High Katherine A,Dir,A - Grant,$0.00,139,139,New,+$0,,,,,INCY
278,D,2020-03-13 16:18:44,2020-03-11,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,128,26096,0%,"+$8,366",,,,,INCY
279,D,2020-02-25 16:39:46,2020-02-21,INCY,Brooke Paul A,Dir,M - OptEx,$13.34,20000,261584,+8%,"+$266,800",,,,,INCY
280,D,2020-02-21 16:11:19,2020-02-19,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,48493,+5%,"+$161,375",,,,,INCY
281,D,2020-02-21 16:11:19,2020-02-19,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,-2500,48493,-5%,"-$200,000",,,,,INCY
282,,2020-02-18 17:00:59,2020-02-13,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,6881,24490,+39%,+$0,,,,,INCY
283,,2020-02-18 16:44:07,2020-02-13,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,6881,73354,+10%,+$0,,,,,INCY
284,,2020-02-18 16:29:24,2020-02-13,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,40360,306837,+15%,+$0,,,,,INCY
285,,2020-02-18 16:22:52,2020-02-13,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,6881,102189,+7%,+$0,,,,,INCY
286,,2020-02-18 16:18:56,2020-02-13,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,6881,48493,+17%,+$0,,,,,INCY
287,,2020-02-18 16:13:49,2020-02-13,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,6881,25968,+36%,+$0,,,,,INCY
288,,2020-02-18 16:05:51,2020-02-13,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,6881,35342,+24%,+$0,,,,,INCY
289,,2020-02-18 16:02:19,2020-02-13,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,6881,19987,+53%,+$0,,,,,INCY
290,D,2020-02-13 17:21:28,2020-02-11,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$76.14,4268,14089,+43%,"+$324,966",,,,,INCY
291,D,2020-02-13 17:21:28,2020-02-11,INCY,Stamoulis Christiana,"EVP, CFO",F - Tax,$76.14,-780,14089,-5%,"-$59,389",,,,,INCY
292,D,2020-02-12 17:00:22,2020-02-10,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,19087,+1%,"+$8,301",,,,,INCY
293,D,2020-02-07 16:48:00,2020-02-05,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$18.32,17542,95308,+23%,"+$321,369",,,,,INCY
294,D,2020-02-07 16:48:00,2020-02-05,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$75.97,-17542,95308,-16%,"-$1,332,666",,,,,INCY
295,,2020-01-27 16:30:42,2020-01-23,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$78.24,-64,48557,0%,"-$5,007",,,,,INCY
296,,2020-01-27 16:12:41,2020-01-23,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$78.24,-64,30351,0%,"-$5,007",,,,,INCY
297,D,2020-01-22 16:44:20,2020-01-17,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,4018,21324,+23%,+$0,,,,,INCY
298,D,2020-01-22 16:39:54,2020-01-17,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,11482,28461,+68%,+$0,,,,,INCY
299,,2020-01-22 16:29:45,2020-01-17,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",A - Grant,$0.00,5741,48621,+13%,+$0,,,,,INCY
300,,2020-01-22 16:29:45,2020-01-17,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$80.50,-59,48621,0%,"-$4,750",,,,,INCY
301,,2020-01-22 16:27:26,2020-01-17,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",A - Grant,$0.00,5741,30415,+23%,+$0,,,,,INCY
302,,2020-01-22 16:27:26,2020-01-17,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$80.50,-59,30415,0%,"-$4,750",,,,,INCY
303,D,2020-01-17 16:20:38,2020-01-15,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,41612,+6%,"+$161,375",,,,,INCY
304,D,2020-01-17 16:20:38,2020-01-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$81.12,-2500,41612,-6%,"-$202,800",,,,,INCY
305,D,2020-01-14 16:54:56,2020-01-10,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,127,18960,+1%,"+$8,301",,,,,INCY
306,,2020-01-08 19:24:38,2020-01-06,INCY,Dickinson Jonathan Elliott,"EVP, GM, Europe",F - Tax,$77.34,-111,24733,0%,"-$8,585",,,,,INCY
307,,2020-01-08 17:05:30,2020-01-06,INCY,Morrissey Michael James,"EVP, Head of Tech. Operations",F - Tax,$77.34,-111,42939,0%,"-$8,585",,,,,INCY
308,,2020-01-03 16:20:23,2020-01-02,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$85.97,-28345,266477,-10%,"-$2,436,820",,,,,INCY
309,,2020-01-03 16:15:22,2019-12-31,INCY,Fouse Jacqualyn A,Dir,A - Grant,$87.32,218,3049,+8%,"+$19,036",,,,,INCY
310,,2020-01-03 16:12:37,2019-12-31,INCY,Dixon Wendy L,Dir,A - Grant,$87.32,196,12536,+2%,"+$17,115",,,,,INCY
311,,2020-01-03 16:09:29,2019-12-31,INCY,Clancy Paul J,Dir,A - Grant,$87.32,231,2457,+10%,"+$20,171",,,,,INCY
312,,2020-01-03 16:07:55,2019-12-31,INCY,Brooke Paul A,Dir,A - Grant,$87.32,264,241584,0%,"+$23,052",,,,,INCY
313,,2020-01-03 16:05:42,2019-12-31,INCY,Bienaime Jean Jacques,Dir,A - Grant,$87.32,190,7464,+3%,"+$16,591",,,,,INCY
314,,2020-01-03 16:01:20,2019-12-31,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$87.32,632,29884896,0%,"+$55,186",,,,,INCY
315,D,2019-12-19 16:52:00,2019-12-17,INCY,Harrigan Edmund,Dir,A - Grant,$0.00,462,462,New,+$0,,,,,INCY
316,D,2019-12-18 16:59:40,2019-12-16,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,41612,+6%,"+$161,375",,,,,INCY
317,D,2019-12-18 16:59:40,2019-12-16,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$91.61,-2500,41612,-6%,"-$229,025",,,,,INCY
318,D,2019-12-16 16:35:05,2019-12-12,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,77,18833,0%,"+$5,033",,,,,INCY
319,,2019-12-12 16:36:41,2019-12-10,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",F - Tax,$95.72,-533,13106,-4%,"-$51,019",,,,,INCY
320,DM,2019-12-03 16:32:39,2019-11-29,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$18.32,20000,95308,+27%,"+$366,400",,,,,INCY
321,DM,2019-12-03 16:32:39,2019-11-29,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$95.00,-20000,95308,-17%,"-$1,900,000",,,,,INCY
322,DM,2019-12-03 16:25:53,2019-11-29,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",M - OptEx,$72.86,7866,17609,+81%,"+$573,117",,,,,INCY
323,DM,2019-12-03 16:25:53,2019-11-29,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$95.00,-7866,17609,-31%,"-$747,270",,,,,INCY
324,DM,2019-12-03 16:20:46,2019-11-29,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$73.21,7182,16979,+73%,"+$525,794",,,,,INCY
325,DM,2019-12-03 16:20:46,2019-11-29,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$95.00,-7182,16979,-30%,"-$682,290",,,,,INCY
326,D,2019-11-26 16:31:05,2019-11-25,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$48.44,2142,16979,+14%,"+$103,758",,,,,INCY
327,D,2019-11-26 16:31:05,2019-11-25,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$90.00,-2142,16979,-11%,"-$192,780",,,,,INCY
328,D,2019-11-26 16:11:48,2019-11-25,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$18.32,15000,95308,+19%,"+$274,800",,,,,INCY
329,D,2019-11-26 16:11:48,2019-11-25,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$90.00,-15000,95308,-14%,"-$1,350,000",,,,,INCY
330,D,2019-11-26 16:06:21,2019-11-25,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$18.32,15000,17306,+650%,"+$274,800",,,,,INCY
331,D,2019-11-26 16:06:21,2019-11-25,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$90.00,-15000,17306,-46%,"-$1,350,000",,,,,INCY
332,D,2019-11-19 17:45:30,2019-11-15,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,41612,+6%,"+$161,375",,,,,INCY
333,D,2019-11-19 17:45:30,2019-11-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$86.46,-2500,41612,-6%,"-$216,150",,,,,INCY
334,D,2019-11-14 17:32:24,2019-11-13,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,76,18756,0%,"+$4,967",,,,,INCY
335,DM,2019-11-08 17:25:18,2019-11-06,INCY,Dixon Wendy L,Dir,M - OptEx,$12.46,53334,12340,-130%,"+$664,542",,,,,INCY
336,DM,2019-11-08 17:25:18,2019-11-06,INCY,Dixon Wendy L,Dir,S - Sale+OE,$83.92,-53334,12340,-81%,"-$4,475,774",,,,,INCY
337,D,2019-11-05 17:23:36,2019-11-01,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$18.32,7960,95308,+9%,"+$145,827",,,,,INCY
338,D,2019-11-05 17:23:36,2019-11-01,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$85.00,-7960,95308,-8%,"-$676,600",,,,,INCY
339,D,2019-11-05 16:33:10,2019-11-01,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$18.32,8500,17306,+97%,"+$155,720",,,,,INCY
340,D,2019-11-05 16:33:10,2019-11-01,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$85.00,-8500,17306,-33%,"-$722,500",,,,,INCY
341,D,2019-10-31 16:10:02,2019-10-30,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,50000,95308,+110%,+$0,,,,,INCY
342,D,2019-10-31 16:10:02,2019-10-29,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$18.32,2040,95308,+2%,"+$37,373",,,,,INCY
343,D,2019-10-31 16:10:02,2019-10-29,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$85.00,-2040,95308,-2%,"-$173,400",,,,,INCY
344,D,2019-10-31 16:07:16,2019-10-29,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$18.32,16500,17306,>999%,"+$302,280",,,,,INCY
345,D,2019-10-31 16:07:16,2019-10-29,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$80.45,-16500,17306,-49%,"-$1,327,500",,,,,INCY
346,,2019-10-31 16:04:13,2019-10-30,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,50000,66473,+304%,+$0,,,,,INCY
347,,2019-10-31 16:00:32,2019-10-29,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$85.00,-930,17609,-5%,"-$79,050",,,,,INCY
348,D,2019-10-24 18:52:50,2019-10-22,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,41612,+6%,"+$161,375",,,,,INCY
349,D,2019-10-24 18:52:50,2019-10-22,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,-2500,41612,-6%,"-$200,000",,,,,INCY
350,D,2019-10-11 16:40:19,2019-10-10,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,77,18680,0%,"+$5,033",,,,,INCY
351,,2019-10-02 17:15:38,2019-09-30,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$74.23,728,29884580,0%,"+$54,039",,,,,INCY
352,,2019-10-02 16:14:53,2019-09-30,INCY,Fouse Jacqualyn A,Dir,A - Grant,$74.23,251,2831,+10%,"+$18,632",,,,,INCY
353,,2019-10-02 16:12:17,2019-09-30,INCY,Dixon Wendy L,Dir,A - Grant,$74.23,225,12340,+2%,"+$16,702",,,,,INCY
354,,2019-10-02 16:08:51,2019-09-30,INCY,Clancy Paul J,Dir,A - Grant,$74.23,266,2226,+14%,"+$19,745",,,,,INCY
355,,2019-10-02 16:06:01,2019-09-30,INCY,Brooke Paul A,Dir,A - Grant,$74.23,304,241320,0%,"+$22,566",,,,,INCY
356,,2019-10-02 16:03:41,2019-09-30,INCY,Bienaime Jean Jacques,Dir,A - Grant,$74.23,219,7274,+3%,"+$16,256",,,,,INCY
357,D,2019-09-19 16:34:15,2019-09-18,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,41612,+6%,"+$161,375",,,,,INCY
358,D,2019-09-19 16:34:15,2019-09-18,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,-2500,41612,-6%,"-$200,000",,,,,INCY
359,,2019-09-19 16:30:24,2019-09-17,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$77.71,-2491,16757,-13%,"-$193,576",,,,,INCY
360,D,2019-09-11 16:29:57,2019-09-09,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,76,18603,0%,"+$4,967",,,,,INCY
361,D,2019-08-19 16:21:23,2019-08-15,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,41612,+6%,"+$161,375",,,,,INCY
362,D,2019-08-19 16:21:23,2019-08-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.96,-2500,41612,-6%,"-$202,400",,,,,INCY
363,D,2019-08-13 16:35:17,2019-08-09,INCY,Pasquale Maria E,"EVP, GC",M - OptEx,$65.36,1223,18527,+7%,"+$79,935",,,,,INCY
364,DM,2019-08-06 18:45:59,2019-08-02,INCY,Friedman Paul A,Dir,M - OptEx,$18.32,100000,315531,+46%,"+$1,832,000",,,,,INCY
365,DM,2019-08-06 18:45:59,2019-08-02,INCY,Friedman Paul A,Dir,S - Sale+OE,$82.69,-100000,315531,-24%,"-$8,268,766",,,,,INCY
366,M,2019-08-05 16:36:41,2019-08-01,INCY,Bienaime Jean Jacques,Dir,S - Sale,$85.07,-1724,7055,-20%,"-$146,654",,,,,INCY
367,,2019-07-18 18:13:25,2019-07-17,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$79.91,-959,19248,-5%,"-$76,634",,,,,INCY
368,,2019-07-16 17:07:04,2019-07-15,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$81.39,-2400,294822,-1%,"-$195,336",,,,,INCY
369,,2019-07-16 16:57:25,2019-07-15,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$81.39,-639,45308,-1%,"-$52,008",,,,,INCY
370,,2019-07-16 16:52:50,2019-07-15,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$81.39,-291,17306,-2%,"-$23,684",,,,,INCY
371,D,2019-07-16 16:48:40,2019-07-15,INCY,Swain Paula J,"EVP, HR",F - Tax,$81.39,-639,41612,-2%,"-$52,008",,,,,INCY
372,D,2019-07-16 16:48:40,2019-07-15,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,41612,+6%,"+$161,375",,,,,INCY
373,D,2019-07-16 16:48:40,2019-07-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,-2500,41612,-6%,"-$200,000",,,,,INCY
374,,2019-07-16 16:45:39,2019-07-15,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$81.39,-409,16473,-2%,"-$33,289",,,,,INCY
375,,2019-07-16 16:42:32,2019-07-15,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$81.39,-430,20207,-2%,"-$34,998",,,,,INCY
376,,2019-07-09 16:54:52,2019-07-05,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$85.28,-404,45947,-1%,"-$34,453",,,,,INCY
377,,2019-07-09 16:49:28,2019-07-05,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$85.28,-148,17597,-1%,"-$12,621",,,,,INCY
378,,2019-07-09 16:47:22,2019-07-05,INCY,Swain Paula J,"EVP, HR",F - Tax,$85.28,-404,42251,-1%,"-$34,453",,,,,INCY
379,,2019-07-09 16:43:23,2019-07-05,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$85.28,-267,16882,-2%,"-$22,770",,,,,INCY
380,,2019-07-09 16:40:56,2019-07-05,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",F - Tax,$85.28,-273,18539,-1%,"-$23,281",,,,,INCY
381,,2019-07-09 16:37:48,2019-07-05,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$85.28,-1552,297222,-1%,"-$132,355",,,,,INCY
382,,2019-07-09 16:34:35,2019-07-05,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$85.28,-273,20637,-1%,"-$23,281",,,,,INCY
383,D,2019-07-03 15:08:07,2019-07-02,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,39648,381400,+12%,+$0,,,,,INCY
384,D,2019-07-03 15:08:07,2019-07-02,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$85.01,-2410,381400,-1%,"-$204,874",,,,,INCY
385,D,2019-07-03 14:58:00,2019-07-02,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,6761,46351,+17%,+$0,,,,,INCY
386,D,2019-07-03 14:58:00,2019-07-02,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$85.01,-619,46351,-1%,"-$52,621",,,,,INCY
387,D,2019-07-03 14:54:34,2019-07-02,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,3770,17745,+27%,+$0,,,,,INCY
388,D,2019-07-03 14:54:34,2019-07-02,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$85.01,-336,17745,-2%,"-$28,563",,,,,INCY
389,D,2019-07-03 14:50:19,2019-07-02,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,6761,42655,+19%,+$0,,,,,INCY
390,D,2019-07-03 14:50:19,2019-07-02,INCY,Swain Paula J,"EVP, HR",F - Tax,$85.01,-619,42655,-1%,"-$52,621",,,,,INCY
391,D,2019-07-03 14:46:24,2019-07-02,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,6761,17149,+65%,+$0,,,,,INCY
392,D,2019-07-03 14:46:24,2019-07-02,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$85.01,-417,17149,-2%,"-$35,449",,,,,INCY
393,D,2019-07-03 14:43:15,2019-07-02,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,6761,17304,+64%,+$0,,,,,INCY
394,D,2019-07-03 14:43:15,2019-07-02,INCY,Pasquale Maria E,"EVP, GC",F - Tax,$85.01,-470,17304,-3%,"-$39,955",,,,,INCY
395,D,2019-07-03 14:39:01,2019-07-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,6761,18812,+56%,+$0,,,,,INCY
396,D,2019-07-03 14:39:01,2019-07-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",F - Tax,$85.01,-417,18812,-2%,"-$35,449",,,,,INCY
397,D,2019-07-03 14:35:30,2019-07-02,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,6761,20910,+48%,+$0,,,,,INCY
398,D,2019-07-03 14:35:30,2019-07-02,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$85.01,-417,20910,-2%,"-$35,449",,,,,INCY
399,D,2019-07-03 14:31:44,2019-07-02,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,6761,13639,+98%,+$0,,,,,INCY
400,,2019-07-02 16:39:36,2019-06-28,INCY,Fouse Jacqualyn A,Dir,A - Grant,$84.96,203,2580,+9%,"+$17,247",,,,,INCY
401,,2019-07-02 16:33:48,2019-06-28,INCY,Dixon Wendy L,Dir,A - Grant,$84.96,208,12115,+2%,"+$17,672",,,,,INCY
402,,2019-07-02 16:31:18,2019-06-28,INCY,Clancy Paul J,Dir,A - Grant,$84.96,237,1960,+14%,"+$20,136",,,,,INCY
403,,2019-07-02 16:27:22,2019-06-28,INCY,Brooke Paul A,Dir,A - Grant,$84.96,291,241016,0%,"+$24,723",,,,,INCY
404,,2019-07-02 16:23:07,2019-06-28,INCY,Bienaime Jean Jacques,Dir,A - Grant,$84.96,195,8779,+2%,"+$16,567",,,,,INCY
405,,2019-07-02 16:05:54,2019-06-28,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$84.96,620,29884216,0%,"+$52,675",,,,,INCY
406,,2019-06-25 17:46:58,2019-06-24,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale,$87.96,-8357,10805,-44%,"-$735,082",,,,,INCY
407,D,2019-06-18 17:26:28,2019-06-17,INCY,Swain Paula J,"EVP, HR",M - OptEx,$64.55,2500,36513,+7%,"+$161,375",,,,,INCY
408,D,2019-06-18 17:26:28,2019-06-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$80.00,-2500,36513,-6%,"-$200,000",,,,,INCY
409,,2019-05-10 16:38:41,2019-05-09,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",F - Tax,$82.02,-1434,12468,-10%,"-$117,617",,,,,INCY
410,D,2019-04-30 18:01:37,2019-04-26,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,4560,965693,0%,+$0,,,,,INCY
411,D,2019-04-29 17:20:17,2019-04-26,INCY,Friedman Paul A,Dir,A - Grant,$0.00,1520,270531,+1%,+$0,,,,,INCY
412,D,2019-04-29 17:11:47,2019-04-26,INCY,Fouse Jacqualyn A,Dir,A - Grant,$0.00,1520,2377,+177%,+$0,,,,,INCY
413,D,2019-04-29 17:07:49,2019-04-26,INCY,Dixon Wendy L,Dir,A - Grant,$0.00,1520,11907,+15%,+$0,,,,,INCY
414,D,2019-04-29 17:04:26,2019-04-26,INCY,Clancy Paul J,Dir,A - Grant,$0.00,1520,1723,+749%,+$0,,,,,INCY
415,D,2019-04-29 16:57:46,2019-04-26,INCY,Brooke Paul A,Dir,A - Grant,$0.00,1520,240725,+1%,+$0,,,,,INCY
416,D,2019-04-29 16:47:57,2019-04-26,INCY,Bienaime Jean Jacques,Dir,A - Grant,$0.00,1520,8584,+22%,+$0,,,,,INCY
417,,2019-04-11 17:03:45,2019-04-09,INCY,Pasquale Maria E,"EVP, GC",F - Tax,$82.73,-517,11013,-4%,"-$42,771",,,,,INCY
418,,2019-04-02 17:21:30,2019-03-29,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$86.01,660,964173,0%,"+$56,767",,,,,INCY
419,,2019-04-02 17:08:42,2019-03-29,INCY,Clancy Paul J,Dir,A - Grant,$86.01,203,203,New,"+$17,460",,,,,INCY
420,D,2019-04-02 16:51:36,2019-04-01,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,10000,73026,+16%,"+$183,200",,,,,INCY
421,D,2019-04-02 16:51:36,2019-04-01,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$87.01,-10000,73026,-12%,"-$870,100",,,,,INCY
422,,2019-04-02 16:47:55,2019-03-29,INCY,Fouse Jacqualyn A,Dir,A - Grant,$86.01,145,857,+20%,"+$12,471",,,,,INCY
423,,2019-04-02 16:44:42,2019-03-29,INCY,Dixon Wendy L,Dir,A - Grant,$86.01,188,10387,+2%,"+$16,170",,,,,INCY
424,,2019-04-02 16:31:55,2019-03-29,INCY,Brooke Paul A,Dir,A - Grant,$86.01,276,239205,0%,"+$23,739",,,,,INCY
425,,2019-04-02 16:28:46,2019-03-29,INCY,Bienaime Jean Jacques,Dir,A - Grant,$86.01,168,7064,+2%,"+$14,450",,,,,INCY
426,D,2019-03-05 16:45:26,2019-03-01,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,10000,36513,+38%,"+$183,200",,,,,INCY
427,D,2019-03-05 16:45:26,2019-03-01,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$86.68,-10000,36513,-21%,"-$866,800",,,,,INCY
428,D,2019-02-27 17:19:03,2019-02-26,INCY,Baker Bros. Advisors LP,"Dir, 10%",M - OptEx,$2.80,40000,30252746,0%,"+$112,000",,,,,INCY
429,,2019-02-19 19:11:06,2019-02-14,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,20971,261536,+9%,+$0,,,,,INCY
430,,2019-02-19 18:52:25,2019-02-14,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,5389,39798,+16%,+$0,,,,,INCY
431,,2019-02-19 18:17:35,2019-02-14,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,5389,36513,+17%,+$0,,,,,INCY
432,,2019-02-19 17:34:00,2019-02-14,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,5389,19162,+39%,+$0,,,,,INCY
433,,2019-02-19 17:30:54,2019-02-14,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,5389,11530,+88%,+$0,,,,,INCY
434,,2019-02-19 17:21:55,2019-02-14,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,5389,13492,+67%,+$0,,,,,INCY
435,,2019-02-19 17:10:57,2019-02-14,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,5389,14333,+60%,+$0,,,,,INCY
436,D,2019-02-13 16:20:42,2019-02-11,INCY,Stamoulis Christiana,"EVP, CFO",A - Grant,$80.21,10285,10285,New,"+$824,960",,,,,INCY
437,D,2019-02-05 16:36:24,2019-02-01,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,10000,31124,+47%,"+$183,200",,,,,INCY
438,D,2019-02-05 16:36:24,2019-02-01,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$81.19,-10000,31124,-24%,"-$811,900",,,,,INCY
439,,2019-01-30 16:22:52,2019-01-28,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$80.00,-1000,8944,-10%,"-$80,000",,,,,INCY
440,D,2019-01-22 18:04:25,2019-01-17,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$17.79,15354,34409,+81%,"+$273,148",,,,,INCY
441,D,2019-01-22 18:04:25,2019-01-17,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$77.61,-15354,34409,-31%,"-$1,191,624",,,,,INCY
442,D,2019-01-17 16:15:32,2019-01-15,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,5813,13900,+72%,"+$103,413",,,,,INCY
443,D,2019-01-17 16:15:32,2019-01-15,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$75.00,-5813,13900,-29%,"-$435,975",,,,,INCY
444,,2019-01-10 16:11:59,2019-01-08,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$75.56,-1714,9944,-15%,"-$129,510",,,,,INCY
445,D,2019-01-08 16:46:22,2019-01-07,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$74.21,-808,34409,-2%,"-$59,962",,,,,INCY
446,D,2019-01-08 16:46:22,2019-01-07,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",M - OptEx,$17.79,10000,34409,+41%,"+$177,900",,,,,INCY
447,D,2019-01-08 16:46:22,2019-01-07,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",S - Sale+OE,$75.00,-10000,34409,-23%,"-$750,000",,,,,INCY
448,D,2019-01-08 16:42:00,2019-01-07,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$74.21,-272,13900,-2%,"-$20,185",,,,,INCY
449,D,2019-01-08 16:42:00,2019-01-07,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,9187,13900,+195%,"+$163,437",,,,,INCY
450,D,2019-01-08 16:42:00,2019-01-07,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$75.00,-9187,13900,-40%,"-$689,025",,,,,INCY
451,D,2019-01-08 16:37:33,2019-01-07,INCY,Swain Paula J,"EVP, HR",F - Tax,$74.21,-1200,31124,-4%,"-$89,052",,,,,INCY
452,D,2019-01-08 16:37:33,2019-01-04,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,30000,31124,>999%,"+$549,600",,,,,INCY
453,D,2019-01-08 16:37:33,2019-01-04,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$70.00,-30000,31124,-49%,"-$2,100,000",,,,,INCY
454,D,2019-01-08 16:32:07,2019-01-07,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$74.21,-847,13773,-6%,"-$62,856",,,,,INCY
455,D,2019-01-08 16:22:21,2019-01-07,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$74.21,-4604,240565,-2%,"-$341,663",,,,,INCY
456,D,2019-01-08 16:16:59,2019-01-07,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$74.21,-896,11658,-7%,"-$66,492",,,,,INCY
457,,2019-01-03 16:20:39,2019-01-02,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$63.56,-27630,245169,-10%,"-$1,756,163",,,,,INCY
458,,2019-01-03 16:12:32,2018-12-31,INCY,Fouse Jacqualyn A,Dir,A - Grant,$63.59,196,712,+38%,"+$12,464",,,,,INCY
459,,2019-01-03 16:08:02,2018-12-31,INCY,Dixon Wendy L,Dir,A - Grant,$63.59,255,10199,+3%,"+$16,215",,,,,INCY
460,,2019-01-03 16:05:20,2018-12-31,INCY,Brooke Paul A,Dir,A - Grant,$63.59,373,238929,0%,"+$23,719",,,,,INCY
461,,2019-01-03 16:02:28,2018-12-31,INCY,Bienaime Jean Jacques,Dir,A - Grant,$63.59,228,6896,+3%,"+$14,499",,,,,INCY
462,,2019-01-02 16:10:05,2018-12-31,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$63.59,894,963953,0%,"+$56,849",,,,,INCY
463,D,2018-12-12 16:10:04,2018-12-10,INCY,Dhanak Dashyant,"EVP, Chief Scientific Officer",A - Grant,$0.00,6878,6878,New,+$0,,,,,INCY
464,,2018-11-09 16:21:28,2018-11-08,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$68.77,1000,6668,+18%,"+$68,765",,,,,INCY
465,D,2018-10-05 16:30:43,2018-10-03,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,10000,14172,+240%,"+$177,900",,,,,INCY
466,D,2018-10-05 16:30:43,2018-10-03,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$70.00,-10000,14172,-41%,"-$700,000",,,,,INCY
467,D,2018-10-05 16:29:12,2018-10-03,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,10000,32324,+45%,"+$183,200",,,,,INCY
468,D,2018-10-05 16:29:12,2018-10-03,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$70.00,-10000,32324,-24%,"-$700,000",,,,,INCY
469,,2018-10-05 16:23:36,2018-10-03,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$70.00,-1000,12427,-7%,"-$70,000",,,,,INCY
470,,2018-10-02 16:27:32,2018-09-28,INCY,Brooke Paul A,Dir,A - Grant,$69.08,343,238556,0%,"+$23,694",,,,,INCY
471,,2018-10-02 16:19:03,2018-09-28,INCY,Fouse Jacqualyn A,Dir,A - Grant,$69.08,180,516,+54%,"+$12,434",,,,,INCY
472,,2018-10-02 16:15:38,2018-09-28,INCY,Dixon Wendy L,Dir,A - Grant,$69.08,235,9944,+2%,"+$16,234",,,,,INCY
473,,2018-10-02 16:11:37,2018-09-28,INCY,Bienaime Jean Jacques,Dir,A - Grant,$69.08,209,5668,+4%,"+$14,438",,,,,INCY
474,D,2018-09-06 16:30:27,2018-09-04,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,10000,32324,+45%,"+$183,200",,,,,INCY
475,D,2018-09-06 16:30:27,2018-09-04,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$73.21,-10000,32324,-24%,"-$732,100",,,,,INCY
476,D,2018-08-22 16:02:27,2018-08-21,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,10000,32324,+45%,"+$183,200",,,,,INCY
477,D,2018-08-22 16:02:27,2018-08-21,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$70.00,-10000,32324,-24%,"-$700,000",,,,,INCY
478,,2018-07-18 17:22:48,2018-07-16,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$70.19,-430,35217,-1%,"-$30,182",,,,,INCY
479,,2018-07-18 17:16:42,2018-07-16,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$70.19,-196,14172,-1%,"-$13,757",,,,,INCY
480,,2018-07-18 17:12:05,2018-07-16,INCY,Swain Paula J,"EVP, HR",F - Tax,$70.19,-639,32324,-2%,"-$44,851",,,,,INCY
481,,2018-07-18 17:06:11,2018-07-16,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$70.19,-577,14620,-4%,"-$40,500",,,,,INCY
482,,2018-07-18 16:28:26,2018-07-16,INCY,Huber Reid M,"EVP, Chief Scientific Officer",F - Tax,$70.19,-448,34571,-1%,"-$31,445",,,,,INCY
483,,2018-07-18 16:25:53,2018-07-16,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$70.19,-2359,272799,-1%,"-$165,578",,,,,INCY
484,,2018-07-18 16:12:41,2018-07-16,INCY,Gryska David W,"EVP, CFO",F - Tax,$70.19,-455,10235,-4%,"-$31,936",,,,,INCY
485,,2018-07-18 16:09:11,2018-07-16,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$70.19,-430,13427,-3%,"-$30,182",,,,,INCY
486,D,2018-07-11 16:41:34,2018-07-09,INCY,Swain Paula J,"EVP, HR",M - OptEx,$18.32,10000,32963,+44%,"+$183,200",,,,,INCY
487,D,2018-07-11 16:41:34,2018-07-09,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$71.11,-10000,32963,-23%,"-$711,100",,,,,INCY
488,,2018-07-11 16:39:06,2018-07-09,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale,$71.34,-606,8103,-7%,"-$43,232",,,,,INCY
489,D,2018-07-05 17:18:28,2018-07-05,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$68.28,-1532,275158,-1%,"-$104,605",,,,,INCY
490,D,2018-07-05 17:12:51,2018-07-05,INCY,Gryska David W,"EVP, CFO",F - Tax,$68.28,-280,10690,-3%,"-$19,118",,,,,INCY
491,D,2018-07-05 17:04:46,2018-07-05,INCY,Huber Reid M,"EVP, Chief Scientific Officer",F - Tax,$68.28,-284,35019,-1%,"-$19,392",,,,,INCY
492,D,2018-07-05 16:58:57,2018-07-05,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",F - Tax,$68.28,-273,8709,-3%,"-$18,640",,,,,INCY
493,D,2018-07-05 16:49:48,2018-07-05,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$68.28,-273,13857,-2%,"-$18,640",,,,,INCY
494,D,2018-07-05 16:45:06,2018-07-05,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$68.28,-262,15197,-2%,"-$17,889",,,,,INCY
495,D,2018-07-05 16:28:54,2018-07-05,INCY,Swain Paula J,"EVP, HR",F - Tax,$68.28,-404,32963,-1%,"-$27,585",,,,,INCY
496,D,2018-07-05 16:24:49,2018-07-02,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,2694,14368,+23%,+$0,,,,,INCY
497,D,2018-07-05 16:24:49,2018-07-05,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$68.28,-101,14368,-1%,"-$6,896",,,,,INCY
498,D,2018-07-05 16:22:14,2018-07-05,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$68.28,-273,35647,-1%,"-$18,640",,,,,INCY
499,,2018-07-03 16:14:02,2018-06-29,INCY,Brooke Paul A,Dir,A - Grant,$67.00,354,278213,0%,"+$23,718",,,,,INCY
500,,2018-07-03 16:14:02,2018-06-20,INCY,Brooke Paul A,Dir,G - Gift,$0.00,-40000,278213,+17%,-$0,,,,,INCY
501,,2018-07-03 16:08:48,2018-06-29,INCY,Bienaime Jean Jacques,Dir,A - Grant,$67.00,216,5459,+4%,"+$14,472",,,,,INCY
502,,2018-07-03 16:06:23,2018-06-29,INCY,Dixon Wendy L,Dir,A - Grant,$67.00,242,9709,+3%,"+$16,214",,,,,INCY
503,,2018-07-03 16:02:39,2018-06-29,INCY,Fouse Jacqualyn A,Dir,A - Grant,$67.00,186,336,+124%,"+$12,462",,,,,INCY
504,,2018-07-03 15:32:22,2018-06-29,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$67.00,849,963380,0%,"+$56,883",,,,,INCY
505,D,2018-06-06 16:33:04,2018-06-04,INCY,Brooke Paul A,Dir,M - OptEx,$2.80,20000,217859,+10%,"+$56,000",,,,,INCY
506,,2018-05-08 16:12:10,2018-05-04,INCY,Brooke Paul A,Dir,G - Gift,$0.00,-40000,217859,+22%,-$0,,,,,INCY
507,,2018-05-03 17:05:14,2018-05-02,INCY,Hoppenot Herve,"COB , CEO",P - Purchase,$60.94,15000,276690,+6%,"+$914,100",,,,,INCY
508,D,2018-05-03 16:19:37,2018-05-02,INCY,Baker Bros. Advisors LP,"Dir, 10%",M - OptEx,$9.92,60000,963097,+7%,"+$595,200",,,,,INCY
509,D,2018-05-02 17:04:20,2018-04-30,INCY,Swain Paula J,"EVP, HR",M - OptEx,$17.79,80000,33367,-172%,"+$1,423,200",,,,,INCY
510,D,2018-05-02 17:04:20,2018-04-30,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$62.43,-80000,33367,-71%,"-$4,994,400",,,,,INCY
511,D,2018-04-11 16:54:39,2018-04-09,INCY,Pasquale Maria E,"EVP, GC",A - Grant,$0.00,5928,6141,>999%,+$0,,,,,INCY
512,D,2018-04-09 17:01:24,2018-04-05,INCY,Brooke Paul A,Dir,M - OptEx,$9.92,20000,217859,+10%,"+$198,400",,,,,INCY
513,,2018-04-03 16:30:47,2018-03-29,INCY,Fouse Jacqualyn A,Dir,A - Grant,$83.33,150,150,New,"+$12,500",,,,,INCY
514,,2018-04-03 16:26:24,2018-03-29,INCY,Dixon Wendy L,Dir,A - Grant,$83.33,195,9467,+2%,"+$16,249",,,,,INCY
515,,2018-04-03 16:23:29,2018-03-29,INCY,Brooke Paul A,Dir,A - Grant,$83.33,285,197859,0%,"+$23,749",,,,,INCY
516,,2018-04-03 16:18:15,2018-03-29,INCY,Bienaime Jean Jacques,Dir,A - Grant,$83.33,174,5243,+3%,"+$14,499",,,,,INCY
517,,2018-04-02 17:59:10,2018-03-29,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$83.33,684,943097,0%,"+$56,998",,,,,INCY
518,,2018-03-06 16:30:43,2018-03-02,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$86.61,-2081,15459,-12%,"-$180,235",,,,,INCY
519,,2018-02-22 16:46:22,2018-02-20,INCY,Gryska David W,"EVP, CFO",F - Tax,$86.03,-1070,10970,-9%,"-$92,052",,,,,INCY
520,,2018-02-22 16:46:22,2018-02-21,INCY,Gryska David W,"EVP, CFO",S - Sale,$85.56,-1952,10970,-15%,"-$167,013",,,,,INCY
521,,2018-02-22 16:29:26,2018-02-20,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$86.03,-1026,35584,-3%,"-$88,267",,,,,INCY
522,,2018-02-22 16:23:38,2018-02-20,INCY,Huber Reid M,"EVP, Chief Scientific Officer",F - Tax,$86.03,-1064,35183,-3%,"-$91,536",,,,,INCY
523,,2018-02-22 16:23:38,2018-02-21,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$85.55,-1958,35183,-5%,"-$167,507",,,,,INCY
524,,2018-02-22 16:18:48,2018-02-20,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$86.03,-414,11439,-3%,"-$35,616",,,,,INCY
525,,2018-02-22 16:15:56,2018-02-20,INCY,Swain Paula J,"EVP, HR",F - Tax,$86.03,-1026,33367,-3%,"-$88,267",,,,,INCY
526,,2018-02-22 16:12:23,2018-02-20,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$86.03,-37314,261690,-12%,"-$3,210,123",,,,,INCY
527,,2018-02-22 16:10:06,2018-02-20,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$86.03,-1026,13823,-7%,"-$88,267",,,,,INCY
528,D,2018-01-09 16:09:03,2018-01-05,INCY,Gryska David W,"EVP, CFO",M - OptEx,$83.83,6760,13992,+93%,"+$566,691",,,,,INCY
529,D,2018-01-09 16:09:03,2018-01-05,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$98.87,-6760,13992,-33%,"-$668,361",,,,,INCY
530,D,2018-01-03 16:32:04,2018-01-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",M - OptEx,$72.86,5000,8676,+136%,"+$364,300",,,,,INCY
531,D,2018-01-03 16:32:04,2018-01-02,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",S - Sale+OE,$97.26,-5000,8676,-37%,"-$486,300",,,,,INCY
532,,2018-01-03 16:12:23,2017-12-29,INCY,Dixon Wendy L,Dir,A - Grant,$94.71,171,9272,+2%,"+$16,195",,,,,INCY
533,,2018-01-03 16:09:21,2017-12-29,INCY,Brooke Paul A,Dir,A - Grant,$94.71,250,197574,0%,"+$23,678",,,,,INCY
534,,2018-01-03 16:05:54,2017-12-29,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$94.71,600,942869,0%,"+$56,826",,,,,INCY
535,,2018-01-03 16:04:53,2017-12-29,INCY,Bienaime Jean Jacques,Dir,A - Grant,$94.71,153,5069,+3%,"+$14,491",,,,,INCY
536,,2017-12-05 16:01:25,2017-12-01,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$98.01,-696,38205,-2%,"-$68,215",,,,,INCY
537,,2017-11-20 16:25:24,2017-11-16,INCY,Friedman Paul A,Dir,S - Sale,$105.24,-28507,269011,-10%,"-$3,000,077",,,,,INCY
538,,2017-11-03 16:01:24,2017-11-01,INCY,Gryska David W,"EVP, CFO",F - Tax,$107.96,-3913,13992,-22%,"-$422,447",,,,,INCY
539,,2017-11-03 16:01:24,2017-11-02,INCY,Gryska David W,"EVP, CFO",S - Sale,$105.63,-3915,13992,-22%,"-$413,541",,,,,INCY
540,,2017-10-03 17:30:30,2017-09-29,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$116.74,486,942669,0%,"+$56,736",,,,,INCY
541,,2017-10-03 16:29:53,2017-09-29,INCY,Dixon Wendy L,Dir,A - Grant,$116.74,139,9101,+2%,"+$16,227",,,,,INCY
542,,2017-10-03 16:21:54,2017-09-29,INCY,Brooke Paul A,Dir,A - Grant,$116.74,203,197324,0%,"+$23,698",,,,,INCY
543,,2017-10-03 16:13:38,2017-09-29,INCY,Bienaime Jean Jacques,Dir,A - Grant,$116.74,124,4916,+3%,"+$14,476",,,,,INCY
544,,2017-09-20 16:28:04,2017-09-18,INCY,Hoppenot Herve,"COB , CEO",S - Sale,$119.45,-70502,299004,-19%,"-$8,421,464",,,,,INCY
545,,2017-09-15 16:39:54,2017-09-13,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$123.15,-674,36610,-2%,"-$83,003",,,,,INCY
546,,2017-09-15 16:35:22,2017-09-13,INCY,Swain Paula J,"EVP, HR",F - Tax,$123.15,-674,34393,-2%,"-$83,003",,,,,INCY
547,,2017-09-15 16:31:20,2017-09-13,INCY,Stein Steven H,"EVP, Chief Medical Officer",F - Tax,$123.15,-625,17540,-3%,"-$76,969",,,,,INCY
548,,2017-09-15 16:28:33,2017-09-13,INCY,Siegel Eric H.,"EVP, GC",F - Tax,$123.15,-680,21053,-3%,"-$83,742",,,,,INCY
549,,2017-09-15 16:24:46,2017-09-13,INCY,Huber Reid M,"EVP, Chief Scientific Officer",F - Tax,$123.15,-692,38862,-2%,"-$85,220",,,,,INCY
550,,2017-09-15 16:19:58,2017-09-13,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$123.15,-2486,369506,-1%,"-$306,151",,,,,INCY
551,,2017-09-15 16:14:27,2017-09-13,INCY,Gryska David W,"EVP, CFO",F - Tax,$123.15,-712,21820,-3%,"-$87,683",,,,,INCY
552,,2017-09-15 16:11:32,2017-09-13,INCY,Flannelly Barry P,"EVP, GM US",F - Tax,$123.15,-674,14782,-4%,"-$83,003",,,,,INCY
553,,2017-09-15 16:11:32,2017-09-14,INCY,Flannelly Barry P,"EVP, GM US",S - Sale,$124.25,-714,14782,-5%,"-$88,715",,,,,INCY
554,,2017-09-08 17:06:12,2017-09-08,INCY,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$132.00,100000,942507,+12%,"+$13,200,000",,,,,INCY
555,D,2017-09-07 16:04:50,2017-09-05,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,3000,26706,+13%,"+$53,370",,,,,INCY
556,D,2017-09-07 16:04:50,2017-09-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$138.41,-3000,26706,-10%,"-$415,230",,,,,INCY
557,D,2017-09-05 16:27:01,2017-09-01,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$64.55,1820,21733,+9%,"+$117,481",,,,,INCY
558,D,2017-09-05 16:27:01,2017-09-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$137.40,-1820,21733,-8%,"-$250,068",,,,,INCY
559,D,2017-09-05 16:22:33,2017-08-31,INCY,Swain Paula J,"EVP, HR",M - OptEx,$17.79,20000,35067,+133%,"+$355,800",,,,,INCY
560,D,2017-09-05 16:22:33,2017-08-31,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$140.00,-20000,35067,-36%,"-$2,800,000",,,,,INCY
561,D,2017-08-31 16:13:38,2017-08-29,INCY,Stein Steven H,"EVP, Chief Medical Officer",M - OptEx,$89.52,2111,18165,+13%,"+$188,974",,,,,INCY
562,D,2017-08-31 16:13:38,2017-08-29,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$125.00,-2111,18165,-10%,"-$263,875",,,,,INCY
563,D,2017-08-07 16:33:21,2017-08-03,INCY,Trower Paul,Principal Accounting Officer,F - Tax,$125.98,-295,26706,-1%,"-$37,164",,,,,INCY
564,D,2017-08-07 16:33:21,2017-08-04,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,3000,26706,+13%,"+$53,370",,,,,INCY
565,D,2017-08-07 16:33:21,2017-08-04,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$125.25,-3000,26706,-10%,"-$375,750",,,,,INCY
566,D,2017-08-03 16:54:36,2017-08-01,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$64.55,1820,21733,+9%,"+$117,481",,,,,INCY
567,D,2017-08-03 16:54:36,2017-08-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$132.92,-1820,21733,-8%,"-$241,914",,,,,INCY
568,D,2017-07-21 16:01:05,2017-07-20,INCY,Stein Steven H,"EVP, Chief Medical Officer",M - OptEx,$85.68,6485,18165,+56%,"+$555,641",,,,,INCY
569,D,2017-07-21 16:01:05,2017-07-20,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$131.09,-6485,18165,-26%,"-$850,119",,,,,INCY
570,D,2017-07-07 17:03:47,2017-07-05,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,3517,16170,+28%,+$0,,,,,INCY
571,D,2017-07-07 17:02:00,2017-07-05,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,1198,12148,+11%,+$0,,,,,INCY
572,D,2017-07-07 17:02:00,2017-07-05,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,3000,12148,+33%,"+$53,370",,,,,INCY
573,D,2017-07-07 17:02:00,2017-07-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$126.18,-3000,12148,-20%,"-$378,540",,,,,INCY
574,D,2017-07-07 16:59:07,2017-07-05,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,13679,371992,+4%,+$0,,,,,INCY
575,D,2017-07-07 16:56:25,2017-07-05,INCY,Gryska David W,"EVP, CFO",A - Grant,$0.00,3517,22532,+18%,+$0,,,,,INCY
576,D,2017-07-07 16:54:31,2017-07-05,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,3517,37284,+10%,+$0,,,,,INCY
577,D,2017-07-07 16:51:59,2017-07-05,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,3517,8510,+70%,+$0,,,,,INCY
578,D,2017-07-07 16:50:18,2017-07-05,INCY,Siegel Eric H.,"EVP, GC",A - Grant,$0.00,3517,21733,+19%,+$0,,,,,INCY
579,D,2017-07-07 16:46:40,2017-07-05,INCY,Huber Reid M,"EVP, Chief Scientific Officer",A - Grant,$0.00,3517,39554,+10%,+$0,,,,,INCY
580,D,2017-07-07 16:43:31,2017-07-05,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,3517,35067,+11%,+$0,,,,,INCY
581,D,2017-07-07 16:39:12,2017-07-05,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,3517,18165,+24%,+$0,,,,,INCY
582,D,2017-07-05 18:20:57,2017-07-03,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$64.55,1820,18216,+11%,"+$117,481",,,,,INCY
583,D,2017-07-05 18:20:57,2017-07-03,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$126.20,-1820,18216,-9%,"-$229,684",,,,,INCY
584,,2017-07-05 16:23:13,2017-06-30,INCY,Dixon Wendy L,Dir,A - Grant,$125.91,129,8962,+1%,"+$16,242",,,,,INCY
585,,2017-07-05 16:21:30,2017-06-30,INCY,Brooke Paul A,Dir,A - Grant,$125.91,188,197121,0%,"+$23,671",,,,,INCY
586,,2017-07-05 16:17:57,2017-06-30,INCY,Bienaime Jean Jacques,Dir,A - Grant,$125.91,115,4792,+2%,"+$14,480",,,,,INCY
587,D,2017-07-05 16:12:24,2017-06-30,INCY,Gryska David W,"EVP, CFO",M - OptEx,$73.21,599,19015,+3%,"+$43,853",,,,,INCY
588,D,2017-07-05 16:12:24,2017-06-30,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$129.74,-599,19015,-3%,"-$77,714",,,,,INCY
589,D,2017-06-22 16:29:42,2017-06-20,INCY,Stein Steven H,"EVP, Chief Medical Officer",M - OptEx,$91.45,9883,14648,+207%,"+$903,824",,,,,INCY
590,D,2017-06-22 16:29:42,2017-06-20,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$125.00,-9883,14648,-40%,"-$1,235,375",,,,,INCY
591,D,2017-06-14 16:50:23,2017-06-12,INCY,Gryska David W,"EVP, CFO",M - OptEx,$73.21,16756,19015,+742%,"+$1,226,707",,,,,INCY
592,D,2017-06-14 16:50:23,2017-06-12,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$116.60,-16756,19015,-47%,"-$1,953,750",,,,,INCY
593,D,2017-06-07 16:21:49,2017-06-06,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$66.66,1292,18216,+8%,"+$86,127",,,,,INCY
594,D,2017-06-07 16:12:51,2017-06-05,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,3000,10950,+38%,"+$53,370",,,,,INCY
595,D,2017-06-07 16:12:51,2017-06-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$132.50,-3000,10950,-22%,"-$397,500",,,,,INCY
596,D,2017-06-02 16:22:52,2017-06-01,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$64.55,1820,16924,+12%,"+$117,481",,,,,INCY
597,D,2017-06-02 16:22:52,2017-06-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$130.00,-1820,16924,-10%,"-$236,600",,,,,INCY
598,,2017-06-02 16:14:57,2017-05-31,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$131.80,500,4677,+12%,"+$65,900",,,,,INCY
599,,2017-05-17 16:18:08,2017-05-15,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$115.00,500,4177,+14%,"+$57,500",,,,,INCY
600,,2017-05-09 16:38:07,2017-05-05,INCY,Huber Reid M,"EVP, Chief Scientific Officer",F - Tax,$125.00,-7732,36037,-18%,"-$966,500",-1.0,,,,INCY
601,,2017-05-09 16:38:07,2017-05-08,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$119.21,-8577,36037,-19%,"-$1,022,464",-1.0,,,,INCY
602,,2017-05-09 16:33:16,2017-05-05,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",F - Tax,$125.00,-4413,33767,-12%,"-$551,625",-1.0,,,,INCY
603,D,2017-05-09 16:17:15,2017-05-05,INCY,Trower Paul,Principal Accounting Officer,M - OptEx,$17.79,3000,10950,+38%,"+$53,370",-1.0,,,,INCY
604,D,2017-05-09 16:17:15,2017-05-05,INCY,Trower Paul,Principal Accounting Officer,S - Sale+OE,$121.70,-3000,10950,-22%,"-$365,100",-1.0,,,,INCY
605,D,2017-05-02 18:01:07,2017-05-01,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$48.44,2064,12653,+19%,"+$99,980",0.0,-5.0,,,INCY
606,D,2017-05-02 18:01:07,2017-05-01,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$124.73,-5296,12653,-30%,"-$660,564",0.0,-5.0,,,INCY
607,D,2017-05-02 17:52:21,2017-05-01,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$64.55,1820,16924,+12%,"+$117,481",0.0,-5.0,,,INCY
608,D,2017-05-02 17:52:21,2017-05-01,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$124.73,-1820,16924,-10%,"-$227,009",0.0,-5.0,,,INCY
609,D,2017-05-02 17:39:28,2017-04-28,INCY,Gryska David W,"EVP, CFO",M - OptEx,$67.06,1389,19015,+8%,"+$93,146",0.0,-5.0,,,INCY
610,D,2017-05-02 17:39:28,2017-04-28,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$124.26,-1389,19015,-7%,"-$172,597",0.0,-5.0,,,INCY
611,,2017-05-02 16:31:44,2017-04-28,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$124.26,500,3677,+16%,"+$62,130",0.0,-5.0,,,INCY
612,D,2017-04-28 17:10:03,2017-04-27,INCY,Baker Bros. Advisors LP,"Dir, 10%",M - OptEx,$7.26,60000,940328,+7%,"+$435,600",0.0,1.0,,,INCY
613,,2017-04-17 16:56:33,2017-04-13,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$139.66,1000,3177,+46%,"+$139,660",0.0,-2.0,,,INCY
614,D,2017-04-11 16:24:11,2017-04-07,INCY,Stein Steven H,"EVP, Chief Medical Officer",M - OptEx,$89.79,32000,14648,-184%,"+$2,873,160",2.0,-7.0,-13.0,,INCY
615,D,2017-04-11 16:24:11,2017-04-07,INCY,Stein Steven H,"EVP, Chief Medical Officer",S - Sale+OE,$137.89,-32000,14648,-69%,"-$4,412,310",2.0,-7.0,-13.0,,INCY
616,D,2017-04-11 16:19:28,2017-04-10,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$39.13,4043,16785,+32%,"+$158,206",2.0,-7.0,-13.0,,INCY
617,D,2017-04-11 16:19:28,2017-04-10,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$140.18,-4043,16785,-19%,"-$566,748",2.0,-7.0,-13.0,,INCY
618,D,2017-04-11 16:14:55,2017-04-10,INCY,Gryska David W,"EVP, CFO",M - OptEx,$67.06,41528,19015,-184%,"+$2,784,868",2.0,-7.0,-13.0,,INCY
619,D,2017-04-11 16:14:55,2017-04-10,INCY,Gryska David W,"EVP, CFO",S - Sale+OE,$138.00,-41528,19015,-69%,"-$5,730,864",2.0,-7.0,-13.0,,INCY
620,,2017-04-11 16:06:52,2017-04-07,INCY,Bienaime Jean Jacques,Dir,P - Purchase,$139.48,1000,2177,+85%,"+$139,480",2.0,-7.0,-13.0,,INCY
621,,2017-04-04 19:33:30,2017-03-31,INCY,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$133.67,426,920328,0%,"+$56,943",-2.0,-3.0,-13.0,,INCY
622,,2017-03-31 17:21:21,2017-03-31,INCY,Dixon Wendy L,Dir,A - Grant,$133.67,121,8833,+1%,"+$16,174",4.0,1.0,-7.0,,INCY
623,,2017-03-31 17:10:15,2017-03-31,INCY,Brooke Paul A,Dir,A - Grant,$133.67,177,196933,0%,"+$23,660",4.0,1.0,-7.0,,INCY
624,,2017-03-31 17:06:22,2017-03-31,INCY,Bienaime Jean Jacques,Dir,A - Grant,$133.67,108,1177,+10%,"+$14,436",4.0,1.0,-7.0,,INCY
625,D,2017-03-20 16:14:34,2017-03-17,INCY,Brooke Paul A,Dir,M - OptEx,$7.26,20000,196756,+11%,"+$145,200",-5.0,-6.0,-15.0,,INCY
626,D,2017-03-20 16:14:34,2017-03-17,INCY,Brooke Paul A,Dir,S - Sale+OE,$147.75,-20000,196756,-9%,"-$2,955,000",-5.0,-6.0,-15.0,,INCY
627,DM,2017-03-20 16:10:49,2017-03-16,INCY,Friedman Paul A,Dir,M - OptEx,$18.32,50000,297518,+20%,"+$916,000",-5.0,-6.0,-15.0,,INCY
628,DM,2017-03-20 16:10:49,2017-03-16,INCY,Friedman Paul A,Dir,S - Sale+OE,$148.72,-50000,297518,-14%,"-$7,436,164",-5.0,-6.0,-15.0,,INCY
629,,2017-03-01 16:56:12,2017-02-27,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$131.88,-2008,52262,-4%,"-$264,815",0.0,0.0,5.0,,INCY
630,D,2017-02-27 16:54:47,2017-02-23,INCY,Friedman Paul A,Dir,M - OptEx,$18.32,50000,297518,+20%,"+$916,000",-1.0,2.0,4.0,,INCY
631,D,2017-02-27 16:54:47,2017-02-23,INCY,Friedman Paul A,Dir,S - Sale+OE,$120.32,-50000,297518,-14%,"-$6,016,000",-1.0,2.0,4.0,,INCY
632,D,2017-02-22 19:49:20,2017-02-17,INCY,Baker Julian,"Dir, 10%",A - Grant,$0.00,10610782,920186,-109%,+$0,0.0,10.0,16.0,,INCY
633,,2017-01-11 16:21:12,2017-01-09,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$113.55,-11739,52185,-18%,"-$1,332,963",2.0,0.0,6.0,,INCY
634,,2017-01-04 18:01:08,2016-12-30,INCY,Baker Julian,"Dir, 10%",A - Grant,$100.27,567,687000,0%,"+$56,853",2.0,16.0,18.0,,INCY
635,,2016-12-30 17:13:07,2016-12-30,INCY,Dixon Wendy L,Dir,A - Grant,$100.27,162,8712,+2%,"+$16,244",2.0,8.0,21.0,,INCY
636,,2016-12-30 17:10:31,2016-12-30,INCY,Brooke Paul A,Dir,A - Grant,$100.27,236,196756,0%,"+$23,664",2.0,8.0,21.0,,INCY
637,,2016-12-30 17:07:24,2016-12-30,INCY,Bienaime Jean Jacques,Dir,A - Grant,$100.27,144,1069,+16%,"+$14,439",2.0,8.0,21.0,,INCY
638,D,2016-11-17 16:29:54,2016-11-15,INCY,Swain Paula J,"EVP, HR",M - OptEx,$14.72,10000,29248,+52%,"+$147,200",-2.0,1.0,-3.0,,INCY
639,D,2016-11-17 16:29:54,2016-11-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$103.26,-10000,29248,-25%,"-$1,032,600",-2.0,1.0,-3.0,,INCY
640,,2016-11-10 16:34:58,2016-11-09,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$109.95,-2715,63924,-4%,"-$298,514",0.0,-4.0,-4.0,10.0,INCY
641,D,2016-10-24 16:44:53,2016-10-20,INCY,Swain Paula J,"EVP, HR",M - OptEx,$14.72,10000,29248,+52%,"+$147,200",-1.0,-1.0,23.0,41.0,INCY
642,D,2016-10-24 16:44:53,2016-10-20,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$90.00,-10000,29248,-25%,"-$900,000",-1.0,-1.0,23.0,41.0,INCY
643,D,2016-10-11 16:37:46,2016-10-07,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$18.32,11709,66601,+21%,"+$214,509",-2.0,-6.0,0.0,46.0,INCY
644,D,2016-10-11 16:37:46,2016-10-07,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale+OE,$96.40,-11709,66601,-15%,"-$1,128,748",-2.0,-6.0,0.0,46.0,INCY
645,D,2016-10-11 16:33:00,2016-10-07,INCY,Flannelly Barry P,"EVP, GM US",M - OptEx,$48.44,24204,11187,-186%,"+$1,172,442",-2.0,-6.0,0.0,46.0,INCY
646,D,2016-10-11 16:33:00,2016-10-07,INCY,Flannelly Barry P,"EVP, GM US",S - Sale+OE,$97.00,-24204,11187,-68%,"-$2,347,788",-2.0,-6.0,0.0,46.0,INCY
647,,2016-10-04 18:33:14,2016-09-30,INCY,Baker Julian,"Dir, 10%",A - Grant,$94.29,603,686811,0%,"+$56,857",2.0,2.0,-4.0,50.0,INCY
648,,2016-10-04 16:43:07,2016-09-30,INCY,Dixon Wendy L,Dir,A - Grant,$94.29,172,8550,+2%,"+$16,218",2.0,2.0,-4.0,50.0,INCY
649,,2016-10-04 16:41:40,2016-09-30,INCY,Brooke Paul A,Dir,A - Grant,$94.29,251,196520,0%,"+$23,667",2.0,2.0,-4.0,50.0,INCY
650,,2016-10-04 16:39:50,2016-09-30,INCY,Bienaime Jean Jacques,Dir,A - Grant,$94.29,153,925,+20%,"+$14,426",2.0,2.0,-4.0,50.0,INCY
651,D,2016-09-26 16:34:48,2016-09-23,INCY,Swain Paula J,"EVP, HR",M - OptEx,$14.72,20000,29248,+216%,"+$294,400",0.0,6.0,-1.0,57.0,INCY
652,D,2016-09-26 16:34:48,2016-09-23,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$90.00,-20000,29248,-41%,"-$1,800,000",0.0,6.0,-1.0,57.0,INCY
653,,2016-08-02 17:09:00,2016-08-02,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale,$87.96,-10000,66601,-13%,"-$879,600",2.0,-1.0,-9.0,36.0,INCY
654,D,2016-08-02 16:54:23,2016-07-29,INCY,Swain Paula J,"EVP, HR",M - OptEx,$14.72,60000,29248,-195%,"+$883,200",2.0,-1.0,-9.0,36.0,INCY
655,D,2016-08-02 16:54:23,2016-07-29,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$90.00,-60000,29248,-67%,"-$5,400,000",2.0,-1.0,-9.0,36.0,INCY
656,D,2016-07-19 16:46:28,2016-07-15,INCY,Wenqing Yao,"EVP, Head of Discovery Chem",A - Grant,$0.00,5555,36102,+18%,+$0,5.0,4.0,-6.0,37.0,INCY
657,D,2016-07-19 16:45:48,2016-07-15,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,2406,10824,+29%,+$0,5.0,4.0,-6.0,37.0,INCY
658,D,2016-07-19 16:45:01,2016-07-15,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,5555,29248,+23%,+$0,5.0,4.0,-6.0,37.0,INCY
659,D,2016-07-19 16:44:22,2016-07-15,INCY,Stein Steven H,"EVP, Chief Medical Officer",A - Grant,$0.00,5555,14648,+61%,+$0,5.0,4.0,-6.0,37.0,INCY
660,D,2016-07-19 16:43:41,2016-07-15,INCY,Siegel Eric H.,"EVP, GC",A - Grant,$0.00,5555,14384,+63%,+$0,5.0,4.0,-6.0,37.0,INCY
661,D,2016-07-19 16:43:02,2016-07-15,INCY,Huber Reid M,"EVP, Chief Scientific Officer",A - Grant,$0.00,5555,76601,+8%,+$0,5.0,4.0,-6.0,37.0,INCY
662,D,2016-07-19 16:42:06,2016-07-15,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,21603,381806,+6%,+$0,5.0,4.0,-6.0,37.0,INCY
663,D,2016-07-19 16:41:17,2016-07-15,INCY,Gryska David W,"EVP, CFO",A - Grant,$0.00,5555,19015,+41%,+$0,5.0,4.0,-6.0,37.0,INCY
664,D,2016-07-19 16:40:36,2016-07-15,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,5555,11187,+99%,+$0,5.0,4.0,-6.0,37.0,INCY
665,,2016-07-05 17:13:36,2016-06-30,INCY,Baker Julian,"Dir, 10%",A - Grant,$79.98,711,686610,0%,"+$56,866",3.0,7.0,11.0,25.0,INCY
666,,2016-07-05 16:32:15,2016-06-30,INCY,Dixon Wendy L,Dir,A - Grant,$79.98,203,8378,+2%,"+$16,236",3.0,7.0,11.0,25.0,INCY
667,,2016-07-05 16:31:41,2016-06-30,INCY,Brooke Paul A,Dir,A - Grant,$79.98,296,196269,0%,"+$23,674",3.0,7.0,11.0,25.0,INCY
668,,2016-07-05 16:31:10,2016-06-30,INCY,Bienaime Jean Jacques,Dir,A - Grant,$79.98,181,772,+31%,"+$14,476",3.0,7.0,11.0,25.0,INCY
669,D,2016-05-11 17:15:49,2016-05-09,INCY,Iyengar Vijay K,"EVP GPS, BD, Licensing",A - Grant,$0.00,4632,4632,New,+$0,0.0,7.0,15.0,29.0,INCY
670,D,2016-04-05 16:30:13,2016-04-01,INCY,Brooke Paul A,Dir,M - OptEx,$3.86,20000,195973,+11%,"+$77,200",12.0,3.0,-2.0,28.0,INCY
671,,2016-04-04 18:32:25,2016-03-31,INCY,Baker Julian,"Dir, 10%",A - Grant,$72.47,786,686373,0%,"+$56,961",0.0,5.0,1.0,26.0,INCY
672,,2016-04-01 16:11:43,2016-03-31,INCY,Dixon Wendy L,Dir,A - Grant,$72.47,224,8175,+3%,"+$16,233",0.0,8.0,-1.0,27.0,INCY
673,,2016-04-01 16:11:19,2016-03-31,INCY,Brooke Paul A,Dir,A - Grant,$72.47,327,175973,0%,"+$23,698",0.0,8.0,-1.0,27.0,INCY
674,,2016-04-01 16:10:51,2016-03-31,INCY,Bienaime Jean Jacques,Dir,A - Grant,$72.47,200,591,+51%,"+$14,494",0.0,8.0,-1.0,27.0,INCY
675,D,2016-03-17 19:14:13,2016-03-17,INCY,Baker Julian,"Dir, 10%",M - OptEx,$3.86,60000,20423396,0%,"+$231,600",3.0,7.0,23.0,27.0,INCY
676,DM,2016-03-17 19:14:13,2016-03-15,INCY,Baker Julian,"Dir, 10%",P - Purchase,$63.98,800000,20423396,+4%,"+$51,184,194",3.0,7.0,23.0,27.0,INCY
677,D,2016-02-29 16:28:15,2016-02-25,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",M - OptEx,$18.32,6566,30547,+27%,"+$120,289",2.0,-2.0,-6.0,9.0,INCY
678,M,2016-02-26 16:42:36,2016-02-24,INCY,Baker Julian,"Dir, 10%",P - Purchase,$70.79,64290,19681963,0%,"+$4,550,987",-1.0,-2.0,-8.0,11.0,INCY
679,D,2016-02-18 16:31:22,2016-02-16,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$18.32,5377,71046,+8%,"+$98,507",2.0,4.0,-11.0,9.0,INCY
680,M,2016-02-16 20:14:20,2016-02-12,INCY,Baker Julian,"Dir, 10%",P - Purchase,$69.87,887165,19624181,+5%,"+$61,983,797",4.0,3.0,-9.0,14.0,INCY
681,M,2016-02-16 20:13:38,2016-02-11,INCY,Baker Julian,"Dir, 10%",P - Purchase,$63.53,2251427,18824191,+14%,"+$143,029,696",4.0,3.0,-9.0,14.0,INCY
682,D,2016-01-20 16:31:32,2016-01-15,INCY,Swain Paula J,"EVP, HR",M - OptEx,$3.11,13531,23693,+133%,"+$42,081",-1.0,2.0,-4.0,12.0,INCY
683,D,2016-01-20 16:31:32,2016-01-15,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$76.96,-13531,23693,-36%,"-$1,041,346",-1.0,2.0,-4.0,12.0,INCY
684,D,2016-01-20 16:30:59,2016-01-15,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2509,8829,+40%,"+$45,965",-1.0,2.0,-4.0,12.0,INCY
685,D,2016-01-08 16:40:32,2016-01-07,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",A - Grant,$0.00,2610,23981,+12%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
686,D,2016-01-08 16:39:49,2016-01-07,INCY,Trower Paul,Principal Accounting Officer,A - Grant,$0.00,822,8418,+11%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
687,D,2016-01-08 16:39:07,2016-01-07,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,2610,23693,+12%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
688,D,2016-01-08 16:38:33,2016-01-07,INCY,Siegel Eric H.,"EVP, GC",A - Grant,$0.00,2610,6320,+70%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
689,D,2016-01-08 16:37:56,2016-01-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3937,16926,+30%,"+$72,126",-3.0,-14.0,-25.0,-10.0,INCY
690,D,2016-01-08 16:37:56,2016-01-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$101.86,-3937,16926,-19%,"-$401,023",-3.0,-14.0,-25.0,-10.0,INCY
691,D,2016-01-08 16:37:23,2016-01-07,INCY,Huber Reid M,"EVP, Chief Scientific Officer",A - Grant,$0.00,2610,65669,+4%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
692,D,2016-01-08 16:36:48,2016-01-07,INCY,Hoppenot Herve,"COB , CEO",A - Grant,$0.00,10442,360203,+3%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
693,D,2016-01-08 16:36:11,2016-01-07,INCY,Gryska David W,"EVP, CFO",A - Grant,$0.00,2610,13460,+24%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
694,D,2016-01-08 16:35:29,2016-01-07,INCY,Flannelly Barry P,"EVP, GM US",A - Grant,$0.00,2610,5632,+86%,+$0,-3.0,-14.0,-25.0,-10.0,INCY
695,,2016-01-05 18:22:26,2015-12-31,INCY,Baker Julian,"Dir, 10%",A - Grant,$108.45,525,666111,0%,"+$56,936",-2.0,-11.0,-34.0,-23.0,INCY
696,,2015-12-31 16:31:15,2015-12-31,INCY,Hoppenot Herve,"COB , CEO",F - Tax,$109.11,-32297,349761,-8%,"-$3,523,926",-5.0,-12.0,-33.0,-26.0,INCY
697,,2015-12-31 16:30:30,2015-12-31,INCY,Brooke Paul A,Dir,A - Grant,$108.45,218,175466,0%,"+$23,642",-5.0,-12.0,-33.0,-26.0,INCY
698,,2015-12-31 16:29:40,2015-12-31,INCY,Dixon Wendy L,Dir,A - Grant,$108.45,149,7951,+2%,"+$16,159",-5.0,-12.0,-33.0,-26.0,INCY
699,,2015-12-31 16:28:39,2015-12-31,INCY,Bienaime Jean Jacques,Dir,A - Grant,$108.45,133,391,+52%,"+$14,424",-5.0,-12.0,-33.0,-26.0,INCY
700,D,2015-12-14 16:32:46,2015-12-10,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,1936,3710,+109%,"+$35,468",5.0,4.0,-29.0,-28.0,INCY
701,D,2015-12-14 16:32:46,2015-12-10,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$107.96,-1936,3710,-34%,"-$209,011",5.0,4.0,-29.0,-28.0,INCY
702,D,2015-12-09 16:31:06,2015-12-07,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3937,16926,+30%,"+$72,126",2.0,6.0,-12.0,-24.0,INCY
703,D,2015-12-09 16:31:06,2015-12-07,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$106.18,-3937,16926,-19%,"-$418,031",2.0,6.0,-12.0,-24.0,INCY
704,DM,2015-11-19 17:51:48,2015-11-17,INCY,Friedman Paul A,Dir,M - OptEx,$17.79,225000,297518,+310%,"+$4,002,750",-3.0,-1.0,-3.0,-33.0,INCY
705,DM,2015-11-19 17:51:48,2015-11-17,INCY,Friedman Paul A,Dir,S - Sale+OE,$113.83,-225000,297518,-43%,"-$25,612,109",-3.0,-1.0,-3.0,-33.0,INCY
706,D,2015-11-12 16:30:14,2015-11-10,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3710,+149%,"+$40,707",3.0,12.0,2.0,-29.0,INCY
707,D,2015-11-12 16:30:14,2015-11-10,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$104.86,-2222,3710,-37%,"-$232,999",3.0,12.0,2.0,-29.0,INCY
708,D,2015-11-10 20:21:59,2015-11-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3936,16926,+30%,"+$72,108",-3.0,-1.0,-1.0,-36.0,INCY
709,D,2015-11-10 20:21:59,2015-11-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$116.51,-3936,16926,-19%,"-$458,583",-3.0,-1.0,-1.0,-36.0,INCY
710,D,2015-11-05 16:47:10,2015-11-03,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",M - OptEx,$17.79,5000,21371,+31%,"+$88,950",-14.0,-9.0,-7.0,-39.0,INCY
711,D,2015-11-05 16:47:10,2015-11-03,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$124.78,-5786,21371,-21%,"-$721,961",-14.0,-9.0,-7.0,-39.0,INCY
712,D,2015-10-15 16:30:52,2015-10-13,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3355,+196%,"+$40,707",-4.0,-5.0,-8.0,-33.0,INCY
713,D,2015-10-15 16:30:52,2015-10-13,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$101.49,-2222,3355,-40%,"-$225,511",-4.0,-5.0,-8.0,-33.0,INCY
714,D,2015-10-08 16:28:41,2015-10-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3937,16926,+30%,"+$72,126",2.0,2.0,12.0,-24.0,INCY
715,D,2015-10-08 16:28:41,2015-10-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$122.29,-3937,16926,-19%,"-$481,456",2.0,2.0,12.0,-24.0,INCY
716,,2015-10-05 19:04:11,2015-10-01,INCY,Baker Julian,"Dir, 10%",A - Grant,$110.33,516,665936,0%,"+$56,930",-7.0,-13.0,0.0,-38.0,INCY
717,,2015-10-02 16:30:46,2015-10-01,INCY,Dixon Wendy L,Dir,A - Grant,$110.33,147,7802,+2%,"+$16,219",-5.0,-20.0,-8.0,-45.0,INCY
718,,2015-10-02 16:30:21,2015-10-01,INCY,Brooke Paul A,Dir,A - Grant,$110.33,215,175428,0%,"+$23,721",-5.0,-20.0,-8.0,-45.0,INCY
719,,2015-10-02 16:29:41,2015-10-01,INCY,Bienaime Jean Jacques,Dir,A - Grant,$110.33,131,258,+103%,"+$14,453",-5.0,-20.0,-8.0,-45.0,INCY
720,D,2015-09-23 16:35:50,2015-09-21,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$18.32,10000,62865,+19%,"+$183,200",-4.0,-14.0,-8.0,-42.0,INCY
721,D,2015-09-23 16:35:50,2015-09-21,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale+OE,$124.29,-10000,62865,-14%,"-$1,242,900",-4.0,-14.0,-8.0,-42.0,INCY
722,D,2015-09-18 18:33:05,2015-09-16,INCY,Baker Julian,"Dir, 10%",M - OptEx,$0.00,4623926,607132,-115%,+$0,-6.0,-11.0,-14.0,-47.0,INCY
723,D,2015-09-18 17:07:44,2015-09-16,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3355,+196%,"+$40,707",-6.0,-11.0,-14.0,-47.0,INCY
724,D,2015-09-18 17:07:44,2015-09-16,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$130.69,-2222,3355,-40%,"-$290,393",-6.0,-11.0,-14.0,-47.0,INCY
725,,2015-09-15 16:31:40,2015-09-11,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale,$130.00,-4301,16926,-20%,"-$559,130",0.0,-10.0,-24.0,-51.0,INCY
726,D,2015-09-10 16:44:21,2015-09-08,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3937,21227,+23%,"+$72,126",5.0,5.0,-18.0,-47.0,INCY
727,D,2015-09-10 16:44:21,2015-09-08,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$118.90,-3937,21227,-16%,"-$468,109",5.0,5.0,-18.0,-47.0,INCY
728,D,2015-08-17 16:20:45,2015-08-13,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3355,+196%,"+$40,707",-1.0,-10.0,16.0,-41.0,INCY
729,D,2015-08-17 16:20:45,2015-08-13,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$107.69,-2222,3355,-40%,"-$239,287",-1.0,-10.0,16.0,-41.0,INCY
730,D,2015-08-10 16:29:40,2015-08-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3936,21227,+23%,"+$72,108",0.0,2.0,16.0,-32.0,INCY
731,D,2015-08-10 16:29:40,2015-08-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$111.95,-3936,21227,-16%,"-$440,635",0.0,2.0,16.0,-32.0,INCY
732,D,2015-08-10 16:29:09,2015-08-07,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$17.92,8397,62857,+15%,"+$150,486",0.0,2.0,16.0,-32.0,INCY
733,DM,2015-07-16 16:37:56,2015-07-14,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",M - OptEx,$15.91,12850,21539,+148%,"+$204,502",-1.0,-3.0,-8.0,-34.0,INCY
734,DM,2015-07-16 16:37:56,2015-07-14,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$116.70,-12850,21539,-37%,"-$1,499,538",-1.0,-3.0,-8.0,-34.0,INCY
735,D,2015-07-16 16:37:25,2015-07-14,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3355,+196%,"+$40,707",-1.0,-3.0,-8.0,-34.0,INCY
736,D,2015-07-16 16:37:25,2015-07-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$113.61,-2222,3355,-40%,"-$252,441",-1.0,-3.0,-8.0,-34.0,INCY
737,D,2015-07-16 16:36:34,2015-07-15,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$17.79,70217,21227,-143%,"+$1,249,160",-1.0,-3.0,-8.0,-34.0,INCY
738,D,2015-07-16 16:36:34,2015-07-15,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$120.00,-70217,21227,-77%,"-$8,426,040",-1.0,-3.0,-8.0,-34.0,INCY
739,D,2015-07-08 16:52:47,2015-07-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3937,21227,+23%,"+$72,126",2.0,11.0,5.0,-2.0,INCY
740,D,2015-07-08 16:52:47,2015-07-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$107.00,-3937,21227,-16%,"-$421,259",2.0,11.0,5.0,-2.0,INCY
741,,2015-07-06 17:40:42,2015-07-01,INCY,Baker Julian,"Dir, 10%",A - Grant,$104.21,546,549414,0%,"+$56,899",1.0,0.0,-4.0,0.0,INCY
742,,2015-07-06 16:29:05,2015-07-01,INCY,Dixon Wendy L,Dir,A - Grant,$104.21,155,7655,+2%,"+$16,153",1.0,0.0,-4.0,0.0,INCY
743,,2015-07-06 16:28:42,2015-07-01,INCY,Brooke Paul A,Dir,A - Grant,$104.21,213,175213,0%,"+$22,197",1.0,0.0,-4.0,0.0,INCY
744,,2015-07-06 16:28:11,2015-07-01,INCY,Bienaime Jean Jacques,Dir,A - Grant,$104.21,127,127,New,"+$13,235",1.0,0.0,-4.0,0.0,INCY
745,D,2015-06-25 16:28:05,2015-06-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$21.05,11691,3521,-143%,"+$246,046",0.0,0.0,4.0,4.0,INCY
746,D,2015-06-25 16:28:05,2015-06-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$108.24,-11691,3521,-77%,"-$1,265,470",0.0,0.0,4.0,4.0,INCY
747,D,2015-06-23 16:28:35,2015-06-19,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$17.79,20000,21227,>999%,"+$355,800",-4.0,-8.0,5.0,4.0,INCY
748,D,2015-06-23 16:28:35,2015-06-19,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$108.13,-20000,21227,-49%,"-$2,162,600",-4.0,-8.0,5.0,4.0,INCY
749,D,2015-06-16 16:02:26,2015-06-12,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2223,3355,+196%,"+$40,725",1.0,5.0,11.0,2.0,INCY
750,D,2015-06-16 16:02:26,2015-06-12,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$105.31,-2223,3355,-40%,"-$234,104",1.0,5.0,11.0,2.0,INCY
751,D,2015-06-10 16:43:35,2015-06-08,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,3937,21227,+23%,"+$72,126",1.0,-1.0,2.0,2.0,INCY
752,D,2015-06-10 16:43:35,2015-06-08,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$107.58,-3937,21227,-16%,"-$423,542",1.0,-1.0,2.0,2.0,INCY
753,DM,2015-05-28 16:32:32,2015-05-26,INCY,Friedman Paul A,Dir,M - OptEx,$14.72,196751,297518,+195%,"+$2,896,175",2.0,1.0,-3.0,4.0,INCY
754,DM,2015-05-28 16:32:32,2015-05-26,INCY,Friedman Paul A,Dir,S - Sale+OE,$107.23,-196751,297518,-40%,"-$21,096,678",2.0,1.0,-3.0,4.0,INCY
755,D,2015-05-28 16:31:54,2015-05-26,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$20.90,12093,3521,-141%,"+$252,728",2.0,1.0,-3.0,4.0,INCY
756,D,2015-05-28 16:31:54,2015-05-26,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$106.40,-12093,3521,-77%,"-$1,286,636",2.0,1.0,-3.0,4.0,INCY
757,DM,2015-05-26 16:57:50,2015-05-21,INCY,Friedman Paul A,Dir,M - OptEx,$14.72,102243,297518,+52%,"+$1,505,017",1.0,2.0,2.0,8.0,INCY
758,DM,2015-05-26 16:57:50,2015-05-21,INCY,Friedman Paul A,Dir,S - Sale+OE,$108.22,-102243,297518,-26%,"-$11,064,921",1.0,2.0,2.0,8.0,INCY
759,D,2015-05-20 16:09:42,2015-05-18,INCY,Brooke Paul A,Dir,M - OptEx,$7.68,20000,175000,+13%,"+$153,600",-1.0,-2.0,-1.0,-1.0,INCY
760,D,2015-05-15 16:08:11,2015-05-14,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3355,+196%,"+$40,707",1.0,1.0,-3.0,-1.0,INCY
761,D,2015-05-15 16:08:11,2015-05-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$104.99,-2222,3355,-40%,"-$233,288",1.0,1.0,-3.0,-1.0,INCY
762,D,2015-05-12 18:58:45,2015-05-11,INCY,Baker Julian,"Dir, 10%",M - OptEx,$7.68,60000,549232,+12%,"+$460,800",-1.0,3.0,0.0,-5.0,INCY
763,D,2015-05-08 16:02:43,2015-05-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,7412,21227,+54%,"+$135,788",1.0,3.0,3.0,13.0,INCY
764,D,2015-05-08 16:02:43,2015-05-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$99.43,-7412,21227,-26%,"-$736,975",1.0,3.0,3.0,13.0,INCY
765,D,2015-04-24 16:20:49,2015-04-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$35.97,36941,3521,-111%,"+$1,328,838",-6.0,-9.0,0.0,0.0,INCY
766,D,2015-04-24 16:20:49,2015-04-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$107.67,-36941,3521,-91%,"-$3,977,437",-6.0,-9.0,0.0,0.0,INCY
767,,2015-04-21 16:58:46,2015-04-17,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale,$102.04,-7150,21539,-25%,"-$729,586",-1.0,-7.0,-1.0,-1.0,INCY
768,D,2015-04-17 17:10:55,2015-04-16,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$14.74,10060,54460,+23%,"+$148,286",4.0,6.0,5.0,4.0,INCY
769,D,2015-04-16 16:29:37,2015-04-14,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3355,+196%,"+$40,707",-1.0,5.0,4.0,-2.0,INCY
770,D,2015-04-16 16:29:37,2015-04-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$98.72,-2222,3355,-40%,"-$219,356",-1.0,5.0,4.0,-2.0,INCY
771,D,2015-04-14 16:15:39,2015-04-13,INCY,Swain Paula J,"EVP, HR",M - OptEx,$3.11,16469,21083,+357%,"+$51,219",1.0,7.0,6.0,6.0,INCY
772,D,2015-04-14 16:15:39,2015-04-13,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$96.29,-16469,21083,-44%,"-$1,585,800",1.0,7.0,6.0,6.0,INCY
773,DM,2015-04-14 16:14:48,2015-04-10,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",M - OptEx,$17.79,23000,28689,+404%,"+$409,170",1.0,7.0,6.0,6.0,INCY
774,DM,2015-04-14 16:14:48,2015-04-10,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$95.18,-23000,28689,-44%,"-$2,189,250",1.0,7.0,6.0,6.0,INCY
775,D,2015-04-08 16:18:12,2015-04-07,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",M - OptEx,$17.79,5000,28689,+21%,"+$88,950",1.0,8.0,10.0,33.0,INCY
776,D,2015-04-08 16:18:12,2015-04-07,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",S - Sale+OE,$90.13,-20031,28689,-41%,"-$1,805,439",1.0,8.0,10.0,33.0,INCY
777,D,2015-04-08 16:17:36,2015-04-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,25000,21227,-663%,"+$458,000",1.0,8.0,10.0,33.0,INCY
778,D,2015-04-08 16:17:36,2015-04-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$88.77,-25000,21227,-54%,"-$2,219,250",1.0,8.0,10.0,33.0,INCY
779,D,2015-04-01 16:27:38,2015-03-30,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$16.61,113776,2905,-103%,"+$1,889,296",-1.0,2.0,8.0,11.0,INCY
780,D,2015-04-01 16:27:38,2015-03-30,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$93.64,-113776,2905,-98%,"-$10,653,985",-1.0,2.0,8.0,11.0,INCY
781,D,2015-04-01 16:26:37,2015-03-30,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$18.06,34263,44408,+338%,"+$618,813",-1.0,2.0,8.0,11.0,INCY
782,D,2015-04-01 16:26:37,2015-03-30,INCY,Huber Reid M,"EVP, Chief Scientific Officer",S - Sale+OE,$93.66,-34263,44408,-44%,"-$3,209,206",-1.0,2.0,8.0,11.0,INCY
783,D,2015-03-18 16:33:34,2015-03-16,INCY,Swain Paula J,"EVP, HR",M - OptEx,$3.11,17500,21083,+488%,"+$54,425",5.0,1.0,11.0,42.0,INCY
784,D,2015-03-18 16:33:34,2015-03-16,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$89.97,-17500,21083,-45%,"-$1,574,475",5.0,1.0,11.0,42.0,INCY
785,D,2015-03-13 16:28:02,2015-03-12,INCY,Ariko Barry A,Dir,M - OptEx,$5.96,80000,45834,-234%,"+$476,800",2.0,9.0,12.0,39.0,INCY
786,D,2015-03-13 16:28:02,2015-03-12,INCY,Ariko Barry A,Dir,S - Sale+OE,$89.27,-80000,45834,-64%,"-$7,141,600",2.0,9.0,12.0,39.0,INCY
787,D,2015-03-13 16:27:18,2015-03-12,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,2222,3355,+196%,"+$40,707",2.0,9.0,12.0,39.0,INCY
788,D,2015-03-13 16:27:18,2015-03-12,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$89.72,-2222,3355,-40%,"-$199,347",2.0,9.0,12.0,39.0,INCY
789,D,2015-03-10 17:36:13,2015-03-10,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",M - OptEx,$17.90,4404,43720,+11%,"+$78,820",1.0,2.0,3.0,30.0,INCY
790,D,2015-03-10 17:13:04,2015-03-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",M - OptEx,$18.32,25000,21227,-663%,"+$458,000",1.0,2.0,3.0,30.0,INCY
791,D,2015-03-10 17:13:04,2015-03-06,INCY,Levy Richard S,"EVP, Chief Drug Dev Officer",S - Sale+OE,$89.91,-25000,21227,-54%,"-$2,247,750",1.0,2.0,3.0,30.0,INCY
792,D,2015-03-09 16:37:29,2015-03-05,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,13333,3355,-134%,"+$244,261",0.0,0.0,0.0,29.0,INCY
793,D,2015-03-09 16:37:29,2015-03-05,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$90.00,-13333,3355,-80%,"-$1,199,970",0.0,0.0,0.0,29.0,INCY
794,D,2015-03-09 16:35:21,2015-03-05,INCY,De Schutter Richard U,Chairman,M - OptEx,$16.16,40000,92290,+76%,"+$646,200",0.0,0.0,0.0,29.0,INCY
795,D,2015-03-09 16:35:21,2015-03-05,INCY,De Schutter Richard U,Chairman,S - Sale+OE,$92.09,-40000,92290,-30%,"-$3,683,759",0.0,0.0,0.0,29.0,INCY
796,D,2015-02-25 17:29:55,2015-02-25,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$18.32,13333,3355,-134%,"+$244,261",2.0,3.0,6.0,14.0,INCY
797,D,2015-02-25 17:29:55,2015-02-25,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$85.00,-13333,3355,-80%,"-$1,133,305",2.0,3.0,6.0,14.0,INCY
798,DM,2015-02-25 17:29:18,2015-02-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11112,3521,-146%,"+$189,404",2.0,3.0,6.0,14.0,INCY
799,DM,2015-02-25 17:29:18,2015-02-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$82.19,-11112,3521,-76%,"-$913,268",2.0,3.0,6.0,14.0,INCY
800,D,2015-02-20 16:43:54,2015-02-18,INCY,Ariko Barry A,Dir,M - OptEx,$7.68,20000,45834,+77%,"+$153,600",1.0,6.0,16.0,37.0,INCY
801,D,2015-02-20 16:43:54,2015-02-18,INCY,Ariko Barry A,Dir,S - Sale+OE,$78.43,-20000,45834,-30%,"-$1,568,600",1.0,6.0,16.0,37.0,INCY
802,,2015-02-18 17:50:38,2015-02-13,INCY,Hoppenot Herve,CEO,F - Tax,$75.94,-30534,382058,-7%,"-$2,318,752",1.0,3.0,17.0,46.0,INCY
803,,2015-02-18 17:49:41,2015-02-13,INCY,Friedman Paul A,Dir,S - Sale,$74.32,-120000,297518,-29%,"-$8,918,400",1.0,3.0,17.0,46.0,INCY
804,D,2015-02-18 17:49:03,2015-02-17,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$15.66,12000,18205,+193%,"+$187,947",1.0,3.0,17.0,46.0,INCY
805,D,2015-02-18 17:49:03,2015-02-17,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$76.90,-12000,18205,-40%,"-$922,800",1.0,3.0,17.0,46.0,INCY
806,D,2015-02-18 17:47:57,2015-02-17,INCY,Swain Paula J,"EVP, HR",M - OptEx,$3.11,17500,21083,+488%,"+$54,425",1.0,3.0,17.0,46.0,INCY
807,D,2015-02-18 17:47:57,2015-02-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$76.90,-17500,21083,-45%,"-$1,345,750",1.0,3.0,17.0,46.0,INCY
808,D,2015-02-10 16:33:58,2015-02-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$18.32,25000,18205,-368%,"+$458,000",-1.0,2.0,18.0,36.0,INCY
809,D,2015-02-10 16:33:58,2015-02-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$75.11,-25000,18205,-58%,"-$1,877,750",-1.0,2.0,18.0,36.0,INCY
810,D,2015-01-26 16:57:42,2015-01-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11109,3521,-146%,"+$189,352",0.0,-4.0,-2.0,32.0,INCY
811,D,2015-01-26 16:57:42,2015-01-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$77.68,-11109,3521,-76%,"-$862,947",0.0,-4.0,-2.0,32.0,INCY
812,DM,2015-01-26 16:57:19,2015-01-22,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$17.79,13542,3355,-133%,"+$240,912",0.0,-4.0,-2.0,32.0,INCY
813,DM,2015-01-26 16:57:19,2015-01-22,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$79.85,-13542,3355,-80%,"-$1,081,266",0.0,-4.0,-2.0,32.0,INCY
814,D,2015-01-20 17:28:03,2015-01-20,INCY,Swain Paula J,"EVP, HR",M - OptEx,$3.11,17500,21083,+488%,"+$54,425",0.0,7.0,2.0,52.0,INCY
815,D,2015-01-20 17:28:03,2015-01-20,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$74.17,-17500,21083,-45%,"-$1,297,975",0.0,7.0,2.0,52.0,INCY
816,D,2015-01-20 17:27:25,2015-01-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,12000,18205,+193%,"+$176,640",0.0,7.0,2.0,52.0,INCY
817,D,2015-01-20 17:27:25,2015-01-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$73.07,-12000,18205,-40%,"-$876,840",0.0,7.0,2.0,52.0,INCY
818,D,2015-01-12 17:06:26,2015-01-08,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$16.78,15626,3355,-127%,"+$262,194",4.0,2.0,4.0,55.0,INCY
819,D,2015-01-12 17:06:26,2015-01-08,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$75.00,-15626,3355,-82%,"-$1,171,950",4.0,2.0,4.0,55.0,INCY
820,D,2015-01-09 19:03:12,2015-01-08,INCY,Wenqing Yao,"EVP, Discovery Medicinal, P",A - Grant,$0.00,3022,39316,+8%,+$0,2.0,1.0,5.0,50.0,INCY
821,D,2015-01-09 19:02:36,2015-01-08,INCY,Swain Paula J,"EVP, HR",A - Grant,$0.00,3022,21083,+17%,+$0,2.0,1.0,5.0,50.0,INCY
822,D,2015-01-09 19:02:14,2015-01-08,INCY,Siegel Eric H.,"EVP, GC",A - Grant,$0.00,3022,3355,+908%,+$0,2.0,1.0,5.0,50.0,INCY
823,D,2015-01-09 19:01:50,2015-01-08,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",A - Grant,$0.00,3022,21227,+17%,+$0,2.0,1.0,5.0,50.0,INCY
824,D,2015-01-09 19:01:26,2015-01-08,INCY,Huber Reid M,"EVP, Chief Scientific Officer",A - Grant,$0.00,3022,44562,+7%,+$0,2.0,1.0,5.0,50.0,INCY
825,D,2015-01-09 19:01:04,2015-01-08,INCY,Hoppenot Herve,CEO,A - Grant,$0.00,12592,412592,+3%,+$0,2.0,1.0,5.0,50.0,INCY
826,D,2015-01-09 19:00:45,2015-01-08,INCY,Gryska David W,"EVP, CFO",A - Grant,$0.00,3022,10850,+39%,+$0,2.0,1.0,5.0,50.0,INCY
827,D,2015-01-09 19:00:23,2015-01-08,INCY,Flannelly Barry P,"EVP, Business Development",A - Grant,$0.00,3022,3022,New,+$0,2.0,1.0,5.0,50.0,INCY
828,D,2015-01-09 19:00:00,2015-01-08,INCY,Daly James M,"EVP, Chief Commercial Officer",A - Grant,$0.00,3022,3521,+606%,+$0,2.0,1.0,5.0,50.0,INCY
829,D,2015-01-09 18:59:42,2015-01-08,INCY,Chardonnet Laurent,Vice President and Treasurer,A - Grant,$0.00,1152,2905,+66%,+$0,2.0,1.0,5.0,50.0,INCY
830,D,2015-01-08 17:34:26,2015-01-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$18.32,25000,18205,-368%,"+$458,000",-2.0,3.0,3.0,47.0,INCY
831,D,2015-01-08 17:34:26,2015-01-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$71.84,-25000,18205,-58%,"-$1,796,000",-2.0,3.0,3.0,47.0,INCY
832,D,2015-01-07 16:29:30,2015-01-05,INCY,Swain Paula J,"EVP, HR",M - OptEx,$3.11,17500,18061,>999%,"+$54,425",-2.0,2.0,1.0,44.0,INCY
833,D,2015-01-07 16:29:30,2015-01-05,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$73.90,-17500,18061,-49%,"-$1,293,250",-2.0,2.0,1.0,44.0,INCY
834,D,2014-12-29 16:05:48,2014-12-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11113,0,-100%,"+$189,421",-2.0,0.0,10.0,36.0,INCY
835,D,2014-12-29 16:05:48,2014-12-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$74.43,-11113,0,-100%,"-$827,141",-2.0,0.0,10.0,36.0,INCY
836,D,2014-12-18 16:17:36,2014-12-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,12000,18205,+193%,"+$176,640",0.0,-7.0,0.0,41.0,INCY
837,D,2014-12-18 16:17:36,2014-12-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$72.36,-12000,18205,-40%,"-$868,320",0.0,-7.0,0.0,41.0,INCY
838,M,2014-12-03 16:33:52,2014-12-01,INCY,De Schutter Richard U,Chairman,S - Sale,$74.89,-50000,105000,-32%,"-$3,744,358",-1.0,6.0,-1.0,43.0,INCY
839,D,2014-12-03 16:33:40,2014-12-02,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$9.41,6494,41386,+19%,"+$61,109",-1.0,6.0,-1.0,43.0,INCY
840,D,2014-11-26 16:13:45,2014-11-24,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11111,0,-100%,"+$189,387",1.0,0.0,-2.0,48.0,INCY
841,D,2014-11-26 16:13:45,2014-11-24,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$74.08,-11111,0,-100%,"-$823,103",1.0,0.0,-2.0,48.0,INCY
842,D,2014-11-19 16:49:57,2014-11-17,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,12000,18205,+193%,"+$176,640",0.0,3.0,8.0,53.0,INCY
843,D,2014-11-19 16:49:57,2014-11-17,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$69.97,-12000,18205,-40%,"-$839,640",0.0,3.0,8.0,53.0,INCY
844,D,2014-11-14 16:06:42,2014-11-12,INCY,Huber Reid M,"EVP, Chief Scientific Officer",M - OptEx,$6.24,17960,34892,+106%,"+$112,031",0.0,3.0,4.0,54.0,INCY
845,D,2014-11-07 17:08:01,2014-11-06,INCY,Friedman Paul A,Dir,M - OptEx,$10.03,185653,417518,+80%,"+$1,861,617",2.0,3.0,12.0,52.0,INCY
846,D,2014-11-07 17:08:01,2014-11-06,INCY,Friedman Paul A,Dir,S - Sale+OE,$67.87,-185653,417518,-31%,"-$12,600,269",2.0,3.0,12.0,52.0,INCY
847,D,2014-11-04 16:06:55,2014-10-31,INCY,Gryska David W,"EVP, CFO",A - Grant,$0.00,7828,7828,New,+$0,0.0,5.0,10.0,48.0,INCY
848,D,2014-10-24 16:14:10,2014-10-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11111,0,-100%,"+$189,387",4.0,17.0,31.0,84.0,INCY
849,D,2014-10-24 16:14:10,2014-10-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$53.49,-11111,0,-100%,"-$594,327",4.0,17.0,31.0,84.0,INCY
850,D,2014-10-24 16:13:53,2014-10-23,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$3.11,13904,18205,+323%,"+$43,241",4.0,17.0,31.0,84.0,INCY
851,D,2014-10-20 16:10:50,2014-10-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,8000,4301,-216%,"+$117,760",3.0,9.0,38.0,117.0,INCY
852,D,2014-10-20 16:10:50,2014-10-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$49.03,-8000,4301,-65%,"-$392,240",3.0,9.0,38.0,117.0,INCY
853,D,2014-09-25 16:14:36,2014-09-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.04,11111,0,-100%,"+$189,386",2.0,-2.0,13.0,82.0,INCY
854,D,2014-09-25 16:14:36,2014-09-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$47.65,-11111,0,-100%,"-$529,439",2.0,-2.0,13.0,82.0,INCY
855,D,2014-09-18 16:11:14,2014-09-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,8000,4301,-216%,"+$117,760",1.0,1.0,5.0,100.0,INCY
856,D,2014-09-18 16:11:14,2014-09-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$47.58,-8000,4301,-65%,"-$380,640",1.0,1.0,5.0,100.0,INCY
857,D,2014-08-27 16:25:58,2014-08-25,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11111,0,-100%,"+$189,387",-1.0,-4.0,-11.0,59.0,INCY
858,D,2014-08-27 16:25:58,2014-08-25,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$51.96,-11111,0,-100%,"-$577,328",-1.0,-4.0,-11.0,59.0,INCY
859,D,2014-08-19 17:43:05,2014-08-18,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,8000,4301,-216%,"+$117,760",-1.0,2.0,-7.0,52.0,INCY
860,D,2014-08-19 17:43:05,2014-08-18,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$51.97,-8000,4301,-65%,"-$415,760",-1.0,2.0,-7.0,52.0,INCY
861,D,2014-07-25 17:51:43,2014-07-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11111,0,-100%,"+$189,387",0.0,1.0,7.0,68.0,INCY
862,D,2014-07-25 17:51:43,2014-07-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$48.54,-11111,0,-100%,"-$539,328",0.0,1.0,7.0,68.0,INCY
863,D,2014-07-18 17:11:17,2014-07-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,8000,4301,-216%,"+$117,760",1.0,1.0,9.0,56.0,INCY
864,D,2014-07-18 17:11:17,2014-07-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$48.15,-8000,4301,-65%,"-$385,200",1.0,1.0,9.0,56.0,INCY
865,D,2014-06-25 16:03:25,2014-06-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.04,11111,0,-100%,"+$189,386",0.0,1.0,-15.0,35.0,INCY
866,D,2014-06-25 16:03:25,2014-06-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$56.04,-11111,0,-100%,"-$622,605",0.0,1.0,-15.0,35.0,INCY
867,D,2014-06-18 16:02:33,2014-06-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,8000,4301,-216%,"+$117,760",-1.0,-1.0,-20.0,29.0,INCY
868,D,2014-06-18 16:02:33,2014-06-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$53.88,-8000,4301,-65%,"-$431,040",-1.0,-1.0,-20.0,29.0,INCY
869,DM,2014-06-06 18:47:53,2014-06-04,INCY,Hastings David C,CFO,M - OptEx,$8.42,200000,8500,-104%,"+$1,684,430",3.0,2.0,3.0,42.0,INCY
870,DM,2014-06-06 18:47:53,2014-06-04,INCY,Hastings David C,CFO,S - Sale+OE,$52.73,-200000,8500,-96%,"-$10,546,793",3.0,2.0,3.0,42.0,INCY
871,D,2014-05-28 16:25:08,2014-05-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$17.05,11111,0,-100%,"+$189,387",1.0,4.0,15.0,47.0,INCY
872,D,2014-05-28 16:25:08,2014-05-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$48.48,-11111,0,-100%,"-$538,661",1.0,4.0,15.0,47.0,INCY
873,D,2014-05-23 17:07:25,2014-05-21,INCY,Baker Julian,"Dir, 10%",M - OptEx,$7.02,30000,529232,+6%,"+$210,600",4.0,5.0,19.0,50.0,INCY
874,D,2014-05-20 16:09:21,2014-05-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$14.72,8000,4301,-216%,"+$117,760",-3.0,1.0,15.0,42.0,INCY
875,D,2014-05-20 16:09:21,2014-05-16,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$50.68,-8000,4301,-65%,"-$405,440",-3.0,1.0,15.0,42.0,INCY
876,,2014-05-14 16:35:21,2014-05-12,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$54.00,-2058,1753,-54%,"-$111,132",-9.0,-13.0,-5.0,28.0,INCY
877,D,2014-05-06 16:11:00,2014-05-02,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$9.41,34000,3811,-113%,"+$319,940",-3.0,2.0,-2.0,26.0,INCY
878,D,2014-05-06 16:11:00,2014-05-02,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$51.55,-34000,3811,-90%,"-$1,752,700",-3.0,2.0,-2.0,26.0,INCY
879,D,2014-04-30 16:17:31,2014-04-28,INCY,Brooke Paul A,Dir,M - OptEx,$7.02,25000,135000,+23%,"+$175,500",3.0,10.0,2.0,18.0,INCY
880,D,2014-04-25 16:07:45,2014-04-23,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$16.93,30555,0,-100%,"+$517,268",-1.0,10.0,4.0,15.0,INCY
881,D,2014-04-25 16:07:45,2014-04-23,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$47.71,-30555,0,-100%,"-$1,457,779",-1.0,10.0,4.0,15.0,INCY
882,D,2014-02-21 17:09:41,2014-02-20,INCY,Friedman Paul A,Dir,M - OptEx,$3.11,33354,417518,+9%,"+$103,731",3.0,1.0,-9.0,-21.0,INCY
883,D,2014-02-21 17:09:41,2014-02-20,INCY,Friedman Paul A,Dir,S - Sale+OE,$63.51,-33354,417518,-7%,"-$2,118,313",3.0,1.0,-9.0,-21.0,INCY
884,DM,2014-02-19 17:39:37,2014-02-18,INCY,De Schutter Richard U,Chairman,M - OptEx,$8.88,50000,155000,+48%,"+$444,000",4.0,10.0,5.0,-15.0,INCY
885,DM,2014-02-19 17:39:37,2014-02-18,INCY,De Schutter Richard U,Chairman,S - Sale+OE,$65.53,-50000,155000,-24%,"-$3,276,702",4.0,10.0,5.0,-15.0,INCY
886,DM,2014-02-19 17:39:21,2014-02-14,INCY,Friedman Paul A,Dir,M - OptEx,$7.65,771182,417518,-218%,"+$5,903,051",4.0,10.0,5.0,-15.0,INCY
887,DM,2014-02-19 17:39:21,2014-02-14,INCY,Friedman Paul A,Dir,S - Sale+OE,$65.65,-771182,417518,-65%,"-$50,626,827",4.0,10.0,5.0,-15.0,INCY
888,D,2014-02-18 18:05:01,2014-02-13,INCY,Ariko Barry A,Dir,M - OptEx,$7.02,10000,45834,+28%,"+$70,200",-6.0,2.0,-1.0,-22.0,INCY
889,D,2014-02-18 18:05:01,2014-02-13,INCY,Ariko Barry A,Dir,S - Sale+OE,$66.49,-10000,45834,-18%,"-$664,900",-6.0,2.0,-1.0,-22.0,INCY
890,D,2014-02-18 18:04:45,2014-02-13,INCY,Swain Paula J,"EVP, HR",M - OptEx,$10.56,216967,18061,-109%,"+$2,290,590",-6.0,2.0,-1.0,-22.0,INCY
891,D,2014-02-18 18:04:45,2014-02-13,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$66.73,-216967,18061,-92%,"-$14,478,208",-6.0,2.0,-1.0,-22.0,INCY
892,D,2014-02-18 18:04:16,2014-02-13,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$17.28,54855,0,-100%,"+$948,058",-6.0,2.0,-1.0,-22.0,INCY
893,D,2014-02-18 18:04:16,2014-02-13,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$66.67,-56042,0,-100%,"-$3,736,118",-6.0,2.0,-1.0,-22.0,INCY
894,D,2014-02-18 18:03:53,2014-02-13,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$9.24,98334,3193,-103%,"+$908,621",-6.0,2.0,-1.0,-22.0,INCY
895,D,2014-02-18 18:03:53,2014-02-13,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$66.28,-98334,3193,-97%,"-$6,517,578",-6.0,2.0,-1.0,-22.0,INCY
896,DM,2014-02-18 18:03:30,2014-02-13,INCY,Hastings David C,CFO,M - OptEx,$13.00,275000,8500,-103%,"+$3,575,820",-6.0,2.0,-1.0,-22.0,INCY
897,DM,2014-02-18 18:03:30,2014-02-13,INCY,Hastings David C,CFO,S - Sale+OE,$65.86,-275000,8500,-97%,"-$18,112,440",-6.0,2.0,-1.0,-22.0,INCY
898,DM,2014-02-18 18:02:51,2014-02-13,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$8.78,231096,4301,-102%,"+$2,028,559",-6.0,2.0,-1.0,-22.0,INCY
899,DM,2014-02-18 18:02:51,2014-02-13,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$66.34,-231096,4301,-98%,"-$15,330,206",-6.0,2.0,-1.0,-22.0,INCY
900,D,2014-02-18 18:02:27,2014-02-13,INCY,Daly James M,"EVP, Chief Commercial Officer",M - OptEx,$16.98,158331,0,-100%,"+$2,688,127",-6.0,2.0,-1.0,-22.0,INCY
901,D,2014-02-18 18:02:27,2014-02-13,INCY,Daly James M,"EVP, Chief Commercial Officer",S - Sale+OE,$66.49,-158331,0,-100%,"-$10,527,428",-6.0,2.0,-1.0,-22.0,INCY
902,D,2014-01-23 16:59:58,2014-01-21,INCY,Chardonnet Laurent,Vice President and Treasurer,A - Grant,$0.00,1135,3193,+55%,+$0,-3.0,-1.0,-1.0,-26.0,INCY
903,,2014-01-15 17:20:26,2014-01-13,INCY,Hoppenot Herve,"Pres, CEO",A - Grant,$0.00,400000,400000,New,+$0,2.0,4.0,6.0,-24.0,INCY
904,,2013-12-20 16:15:45,2013-12-20,INCY,Friedman Paul A,CEO,F - Tax,$50.11,-24350,417518,-6%,"-$1,220,179",0.0,-3.0,27.0,10.0,INCY
905,D,2013-12-19 16:07:57,2013-12-17,INCY,Whitfield Roy A,Dir,M - OptEx,$7.35,45000,666082,+7%,"+$330,600",2.0,1.0,29.0,13.0,INCY
906,,2013-11-20 16:28:43,2013-11-18,INCY,Whitfield Roy A,Dir,S - Sale,$47.37,-50000,621082,-7%,"-$2,368,500",2.0,2.0,7.0,3.0,INCY
907,D,2013-09-12 16:29:27,2013-09-10,INCY,Friedman Paul A,CEO,M - OptEx,$7.86,376789,391868,>999%,"+$2,962,344",-2.0,-3.0,0.0,70.0,INCY
908,D,2013-09-12 16:29:27,2013-09-10,INCY,Friedman Paul A,CEO,S - Sale+OE,$37.32,-376789,391868,-49%,"-$14,061,765",-2.0,-3.0,0.0,70.0,INCY
909,D,2013-09-09 16:14:04,2013-09-05,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$8.56,41800,2023,-105%,"+$357,862",-2.0,-3.0,2.0,72.0,INCY
910,DM,2013-09-09 16:14:04,2013-09-05,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$37.31,-44834,2023,-96%,"-$1,672,908",-2.0,-3.0,2.0,72.0,INCY
911,D,2013-09-09 16:13:51,2013-09-05,INCY,Swain Paula J,"EVP, HR",M - OptEx,$7.09,94444,18061,-124%,"+$669,608",-2.0,-3.0,2.0,72.0,INCY
912,D,2013-09-09 16:13:51,2013-09-05,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$35.06,-94444,18061,-84%,"-$3,311,207",-2.0,-3.0,2.0,72.0,INCY
913,D,2013-09-09 16:13:40,2013-09-06,INCY,Hastings David C,CFO,M - OptEx,$7.09,100000,8500,-109%,"+$709,000",-2.0,-3.0,2.0,72.0,INCY
914,D,2013-09-09 16:13:40,2013-09-06,INCY,Hastings David C,CFO,S - Sale+OE,$35.16,-100000,8500,-92%,"-$3,516,000",-2.0,-3.0,2.0,72.0,INCY
915,D,2013-09-09 16:13:28,2013-09-06,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$16.95,55978,899,-102%,"+$948,594",-2.0,-3.0,2.0,72.0,INCY
916,D,2013-09-09 16:13:28,2013-09-06,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$35.17,-55978,899,-98%,"-$1,968,746",-2.0,-3.0,2.0,72.0,INCY
917,D,2013-09-09 16:13:13,2013-09-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$11.98,25000,0,-100%,"+$299,500",-2.0,-3.0,2.0,72.0,INCY
918,D,2013-09-09 16:13:13,2013-09-06,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$35.28,-25000,0,-100%,"-$882,000",-2.0,-3.0,2.0,72.0,INCY
919,,2013-08-20 17:53:50,2013-08-19,INCY,Whitfield Roy A,Dir,S - Sale,$26.70,-50000,671082,-7%,"-$1,335,000",33.0,36.0,35.0,131.0,INCY
920,D,2013-06-13 18:49:19,2013-06-11,INCY,Baker Julian,"Dir, 10%",M - OptEx,$4.44,30000,519232,+6%,"+$133,200",-2.0,-6.0,10.0,128.0,INCY
921,,2013-05-21 16:33:58,2013-05-17,INCY,Whitfield Roy A,Dir,S - Sale,$23.08,-40000,721082,-5%,"-$923,200",0.0,6.0,-8.0,109.0,INCY
922,D,2013-05-15 16:17:12,2013-05-13,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$7.09,60000,4301,-108%,"+$425,400",-3.0,-6.0,-9.0,64.0,INCY
923,D,2013-05-15 16:17:12,2013-05-13,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$22.30,-55699,4301,-93%,"-$1,242,088",-3.0,-6.0,-9.0,64.0,INCY
924,D,2013-05-07 16:40:28,2013-05-06,INCY,Friedman Paul A,CEO,M - OptEx,$10.68,23700,391868,+6%,"+$253,088",1.0,9.0,-6.0,82.0,INCY
925,D,2013-04-08 16:04:44,2013-04-05,INCY,Ariko Barry A,Dir,M - OptEx,$4.44,10000,45834,+28%,"+$44,400",1.0,3.0,6.0,91.0,INCY
926,,2013-03-18 16:33:52,2013-03-14,INCY,Whitfield Roy A,Dir,S - Sale,$25.08,-10000,761082,-1%,"-$250,800",-6.0,-6.0,-12.0,50.0,INCY
927,,2013-03-05 16:13:29,2013-03-01,INCY,Whitfield Roy A,Dir,S - Sale,$22.56,-10000,771082,-1%,"-$225,600",2.0,3.0,-3.0,50.0,INCY
928,D,2013-03-01 16:20:23,2013-02-28,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$15.66,50000,280,-101%,"+$782,910",1.0,3.0,2.0,56.0,INCY
929,D,2013-03-01 16:20:23,2013-02-28,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$22.16,-50000,280,-99%,"-$1,108,000",1.0,3.0,2.0,56.0,INCY
930,D,2013-02-28 16:09:34,2013-02-27,INCY,Brooke Paul A,Dir,M - OptEx,$4.44,10000,110000,+10%,"+$44,400",1.0,3.0,5.0,55.0,INCY
931,D,2013-02-22 16:06:18,2013-02-20,INCY,Swain Paula J,"EVP, HR",M - OptEx,$6.00,103283,18061,-121%,"+$619,208",-1.0,6.0,7.0,71.0,INCY
932,D,2013-02-22 16:06:18,2013-02-20,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$21.53,-103283,18061,-85%,"-$2,223,683",-1.0,6.0,7.0,71.0,INCY
933,D,2013-02-20 16:33:54,2013-02-15,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$6.84,98440,0,-100%,"+$673,176",-1.0,-1.0,8.0,24.0,INCY
934,D,2013-02-20 16:33:54,2013-02-15,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$22.48,-98440,0,-100%,"-$2,212,931",-1.0,-1.0,8.0,24.0,INCY
935,D,2013-02-20 16:33:36,2013-02-15,INCY,Hastings David C,CFO,M - OptEx,$6.59,100000,8500,-109%,"+$658,800",-1.0,-1.0,8.0,24.0,INCY
936,D,2013-02-20 16:33:36,2013-02-15,INCY,Hastings David C,CFO,S - Sale+OE,$22.52,-100000,8500,-92%,"-$2,252,000",-1.0,-1.0,8.0,24.0,INCY
937,,2013-02-20 16:33:31,2013-02-19,INCY,Whitfield Roy A,Dir,S - Sale,$21.82,-30000,781082,-4%,"-$654,600",-1.0,-1.0,8.0,24.0,INCY
938,,2012-12-20 17:31:29,2012-12-20,INCY,Friedman Paul A,CEO,F - Tax,$16.15,-16725,318168,-5%,"-$270,109",-2.0,-4.0,15.0,15.0,INCY
939,,2012-12-19 17:05:13,2012-12-17,INCY,De Schutter Richard U,Chairman,P - Purchase,$16.11,45000,197710,+29%,"+$724,950",4.0,-1.0,19.0,21.0,INCY
940,,2012-12-19 17:05:13,2012-12-17,INCY,De Schutter Richard U,Chairman,S - Sale,$16.03,-50000,197710,-20%,"-$801,500",4.0,-1.0,19.0,21.0,INCY
941,D,2012-08-03 17:35:34,2012-08-01,INCY,Baker Julian,"Dir, 10%",M - OptEx,$5.67,10000,14910309,0%,"+$56,700",-1.0,-4.0,8.0,-1.0,INCY
942,D,2012-07-13 16:14:27,2012-07-12,INCY,Ariko Barry A,Dir,M - OptEx,$5.67,10000,35834,+39%,"+$56,700",0.0,-1.0,-28.0,-24.0,INCY
943,D,2012-07-12 16:32:35,2012-07-10,INCY,Friedman Paul A,CEO,M - OptEx,$7.52,25186,334893,+8%,"+$189,442",-1.0,-1.0,-32.0,-30.0,INCY
944,D,2012-07-06 16:08:17,2012-07-05,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$7.09,35700,3034,-109%,"+$253,113",2.0,1.0,-27.0,-30.0,INCY
945,D,2012-07-06 16:08:17,2012-07-05,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$25.11,-35700,3034,-92%,"-$896,405",2.0,1.0,-27.0,-30.0,INCY
946,D,2012-07-03 18:21:09,2012-07-02,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$6.95,36666,3034,-109%,"+$254,829",2.0,4.0,1.0,-30.0,INCY
947,D,2012-07-03 18:21:09,2012-07-02,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$24.15,-36666,3034,-92%,"-$885,484",2.0,4.0,1.0,-30.0,INCY
948,D,2012-06-06 16:55:55,2012-06-04,INCY,Baker Julian,"Dir, 10%",M - OptEx,$6.66,5000,16145386,0%,"+$33,300",0.0,-6.0,9.0,-25.0,INCY
949,,2012-05-25 16:13:47,2012-05-23,INCY,Whitfield Roy A,Dir,G - Gift,$0.00,-2000,821082,0%,-$0,0.0,-8.0,2.0,-20.0,INCY
950,,2012-05-25 16:13:47,2012-05-24,INCY,Whitfield Roy A,Dir,S - Sale,$22.27,-20000,821082,-2%,"-$445,400",0.0,-8.0,2.0,-20.0,INCY
951,D,2012-05-18 16:04:59,2012-05-16,INCY,Brooke Paul A,Dir,M - OptEx,$6.66,5000,100000,+5%,"+$33,300",7.0,4.0,5.0,-22.0,INCY
952,D,2012-05-18 16:04:59,2012-05-16,INCY,Brooke Paul A,Dir,S - Sale+OE,$23.55,-5000,100000,-5%,"-$117,750",7.0,4.0,5.0,-22.0,INCY
953,D,2012-05-18 16:03:51,2012-05-17,INCY,Ariko Barry A,Dir,M - OptEx,$6.66,5000,25834,+24%,"+$33,300",7.0,4.0,5.0,-22.0,INCY
954,D,2012-05-15 17:13:11,2012-05-11,INCY,Swain Paula J,"EVP, HR",M - OptEx,$8.59,147389,18061,-114%,"+$1,266,780",4.0,2.0,-6.0,-25.0,INCY
955,D,2012-05-15 17:13:11,2012-05-11,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$23.22,-147389,18061,-89%,"-$3,422,373",4.0,2.0,-6.0,-25.0,INCY
956,D,2012-05-15 17:12:18,2012-05-14,INCY,Siegel Eric H.,"EVP, GC",M - OptEx,$16.09,56666,0,-100%,"+$911,722",4.0,2.0,-6.0,-25.0,INCY
957,D,2012-05-15 17:12:18,2012-05-14,INCY,Siegel Eric H.,"EVP, GC",S - Sale+OE,$23.12,-57481,0,-100%,"-$1,328,954",4.0,2.0,-6.0,-25.0,INCY
958,D,2012-05-08 17:14:46,2012-05-07,INCY,Friedman Paul A,CEO,M - OptEx,$5.97,225000,309707,+266%,"+$1,343,250",-1.0,2.0,3.0,-22.0,INCY
959,D,2012-05-08 17:14:46,2012-05-07,INCY,Friedman Paul A,CEO,S - Sale+OE,$22.56,-225000,309707,-42%,"-$5,076,000",-1.0,2.0,3.0,-22.0,INCY
960,,2012-05-01 17:10:07,2012-05-01,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$22.70,-13976,1029,-93%,"-$317,255",2.0,0.0,-2.0,-28.0,INCY
961,D,2012-05-01 17:09:24,2012-04-27,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$8.76,30000,0,-100%,"+$262,948",2.0,0.0,-2.0,-28.0,INCY
962,D,2012-05-01 17:09:24,2012-04-27,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$22.95,-30000,0,-100%,"-$688,500",2.0,0.0,-2.0,-28.0,INCY
963,D,2012-03-22 16:09:58,2012-03-21,INCY,Whitfield Roy A,Dir,M - OptEx,$4.27,14000,843082,+2%,"+$59,840",1.0,0.0,-1.0,-3.0,INCY
964,D,2012-03-21 16:02:59,2012-03-19,INCY,Whitfield Roy A,Dir,M - OptEx,$3.27,36000,829082,+5%,"+$117,760",6.0,6.0,2.0,-1.0,INCY
965,,2012-02-21 16:22:33,2012-02-17,INCY,Whitfield Roy A,Dir,S - Sale,$17.53,-20000,793082,-2%,"-$350,656",0.0,-1.0,7.0,12.0,INCY
966,D,2012-01-31 16:08:02,2012-01-31,INCY,De Schutter Richard U,Chairman,M - OptEx,$5.97,65000,160000,+68%,"+$388,100",2.0,2.0,-4.0,45.0,INCY
967,M,2012-01-20 16:47:56,2012-01-18,INCY,Brooke Paul A,Dir,P - Purchase,$17.70,50000,150000,+50%,"+$884,750",1.0,5.0,2.0,44.0,INCY
968,M,2012-01-17 20:43:42,2012-01-12,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$16.37,14625,355839,+4%,"+$239,408",4.0,3.0,8.0,51.0,INCY
969,M,2012-01-17 20:43:02,2012-01-12,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$16.37,543239,12430783,+5%,"+$8,892,707",4.0,3.0,8.0,51.0,INCY
970,,2011-12-20 17:03:49,2011-12-20,INCY,Friedman Paul A,CEO,A - Grant,$0.00,100000,409707,+32%,+$0,3.0,5.0,21.0,62.0,INCY
971,M,2011-12-12 17:23:17,2011-12-08,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.37,403521,11887544,+4%,"+$5,394,595",-5.0,-4.0,14.0,56.0,INCY
972,M,2011-12-12 17:22:31,2011-12-08,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.37,10827,341214,+3%,"+$144,744",-5.0,-4.0,14.0,56.0,INCY
973,M,2011-12-07 17:58:20,2011-12-05,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.75,41620,330387,+14%,"+$572,097",1.0,2.0,22.0,73.0,INCY
974,M,2011-12-07 17:57:13,2011-12-05,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.75,1555134,11484023,+16%,"+$21,376,451",1.0,2.0,22.0,73.0,INCY
975,M,2011-12-01 16:33:01,2011-11-29,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.04,51270,288767,+22%,"+$668,776",-1.0,-8.0,4.0,44.0,INCY
976,M,2011-12-01 16:31:37,2011-11-29,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$13.13,2406179,9928889,+32%,"+$31,588,304",-1.0,-8.0,4.0,44.0,INCY
977,,2011-11-21 16:05:12,2011-11-17,INCY,Dixon Wendy L,Dir,P - Purchase,$13.40,7500,7500,New,"+$100,497",2.0,1.0,19.0,88.0,INCY
978,D,2011-06-23 16:31:49,2011-06-21,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$5.46,40000,13976,-154%,"+$218,400",0.0,3.0,6.0,-22.0,INCY
979,D,2011-06-23 16:31:49,2011-06-21,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$18.61,-40000,13976,-74%,"-$744,395",0.0,3.0,6.0,-22.0,INCY
980,M,2011-06-17 16:20:08,2011-06-16,INCY,Whitfield Roy A,Dir,S - Sale,$18.02,-20000,813082,-2%,"-$360,450",2.0,3.0,8.0,-27.0,INCY
981,D,2011-06-10 17:06:13,2011-06-09,INCY,Hastings David C,CFO,M - OptEx,$5.12,100000,8500,-109%,"+$512,000",-1.0,1.0,11.0,-24.0,INCY
982,D,2011-06-10 17:06:13,2011-06-09,INCY,Hastings David C,CFO,S - Sale+OE,$17.74,-100000,8500,-92%,"-$1,773,500",-1.0,1.0,11.0,-24.0,INCY
983,D,2011-05-19 16:17:45,2011-05-17,INCY,Swain Paula J,"EVP, HR",M - OptEx,$13.80,75000,18061,-132%,"+$1,035,000",0.0,-5.0,-5.0,-33.0,INCY
984,D,2011-05-19 16:17:45,2011-05-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$19.30,-75000,18061,-81%,"-$1,447,636",0.0,-5.0,-5.0,-33.0,INCY
985,M,2011-05-13 16:35:31,2011-05-11,INCY,Whitfield Roy A,Dir,S - Sale,$20.16,-20000,833082,-2%,"-$403,115",0.0,-4.0,-11.0,-34.0,INCY
986,DM,2011-05-11 16:17:53,2011-05-09,INCY,Schreck Patricia A,"EVP, GC",M - OptEx,$5.81,100000,4500,-105%,"+$580,500",3.0,-3.0,-9.0,-33.0,INCY
987,DM,2011-05-11 16:17:53,2011-05-09,INCY,Schreck Patricia A,"EVP, GC",S - Sale+OE,$20.24,-100000,4500,-96%,"-$2,024,100",3.0,-3.0,-9.0,-33.0,INCY
988,M,2011-05-09 16:13:46,2011-05-05,INCY,Whitfield Roy A,Dir,S - Sale,$19.51,-20000,853082,-2%,"-$390,215",3.0,-2.0,-16.0,-34.0,INCY
989,,2011-05-09 16:13:16,2011-05-06,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$19.55,-5343,13976,-28%,"-$104,456",3.0,-2.0,-16.0,-34.0,INCY
990,D,2011-04-13 16:09:01,2011-04-11,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,M - OptEx,$5.46,100000,66504,-299%,"+$546,000",0.0,-2.0,17.0,-7.0,INCY
991,D,2011-04-13 16:09:01,2011-04-11,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,S - Sale+OE,$17.41,-100000,66504,-60%,"-$1,741,000",0.0,-2.0,17.0,-7.0,INCY
992,D,2011-04-08 16:19:10,2011-04-07,INCY,Schreck Patricia A,"EVP, GC",M - OptEx,$3.83,100000,4500,-105%,"+$382,600",1.0,2.0,18.0,-7.0,INCY
993,D,2011-04-08 16:19:10,2011-04-07,INCY,Schreck Patricia A,"EVP, GC",S - Sale+OE,$16.50,-100000,4500,-96%,"-$1,650,000",1.0,2.0,18.0,-7.0,INCY
994,D,2011-04-08 16:18:48,2011-04-08,INCY,Chardonnet Laurent,Vice President and Treasurer,M - OptEx,$3.11,25000,11319,-183%,"+$77,750",1.0,2.0,18.0,-7.0,INCY
995,D,2011-04-08 16:18:48,2011-04-08,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale+OE,$17.01,-25000,11319,-69%,"-$425,126",1.0,2.0,18.0,-7.0,INCY
996,,2011-04-07 16:17:33,2011-04-05,INCY,Whitfield Roy A,Dir,S - Sale,$16.01,-10000,873082,-1%,"-$160,147",5.0,6.0,20.0,-8.0,INCY
997,,2011-03-25 17:13:02,2011-03-25,INCY,Whitfield Roy A,Dir,S - Sale,$14.65,-10000,883082,-1%,"-$146,528",1.0,9.0,19.0,-9.0,INCY
998,D,2011-03-25 17:09:22,2011-03-25,INCY,Ariko Barry A,Dir,M - OptEx,$14.13,20834,20834,New,"+$294,384",1.0,9.0,19.0,-9.0,INCY
999,DM,2011-03-18 16:13:17,2011-03-16,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,M - OptEx,$9.85,210000,66504,-146%,"+$2,068,100",-2.0,3.0,26.0,5.0,INCY
1000,DM,2011-03-18 16:13:17,2011-03-16,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,S - Sale+OE,$14.26,-210000,66504,-76%,"-$2,995,427",-2.0,3.0,26.0,5.0,INCY
1001,D,2011-02-24 16:12:29,2011-02-23,INCY,Friedman Paul A,CEO,M - OptEx,$8.64,20000,309707,+7%,"+$172,800",3.0,1.0,9.0,8.0,INCY
1002,D,2011-02-22 16:18:05,2011-02-17,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,M - OptEx,$5.97,50000,66504,+303%,"+$298,500",-2.0,0.0,2.0,5.0,INCY
1003,D,2011-02-22 16:18:05,2011-02-17,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,S - Sale+OE,$14.35,-50000,66504,-43%,"-$717,500",-2.0,0.0,2.0,5.0,INCY
1004,D,2011-01-20 16:16:02,2011-01-18,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$6.70,40310,0,-100%,"+$270,139",-3.0,-1.0,-7.0,27.0,INCY
1005,D,2011-01-20 16:16:02,2011-01-18,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$15.80,-40310,0,-100%,"-$636,847",-3.0,-1.0,-7.0,27.0,INCY
1006,M,2010-12-23 16:05:57,2010-12-22,INCY,Whitfield Roy A,Dir,S - Sale,$17.01,-20000,896082,-2%,"-$340,228",-1.0,-1.0,-15.0,9.0,INCY
1007,M,2010-11-18 16:07:25,2010-11-16,INCY,Whitfield Roy A,Dir,S - Sale,$15.99,-11000,916082,-1%,"-$175,942",0.0,-1.0,-2.0,23.0,INCY
1008,M,2010-10-26 16:53:48,2010-10-22,INCY,Whitfield Roy A,Dir,S - Sale,$16.97,-34253,927082,-4%,"-$581,251",1.0,-1.0,-11.0,6.0,INCY
1009,M,2010-09-23 17:49:01,2010-09-21,INCY,"14159 Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,-32152,237497,-12%,"-$478,320",2.0,7.0,12.0,-5.0,INCY
1010,M,2010-09-23 17:47:41,2010-09-21,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,-397050,2933021,-12%,"-$5,906,851",2.0,7.0,12.0,-5.0,INCY
1011,M,2010-09-23 17:46:25,2010-09-21,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,-32388,239258,-12%,"-$481,831",2.0,7.0,12.0,-5.0,INCY
1012,M,2010-09-23 17:43:42,2010-09-21,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,-21623,159739,-12%,"-$321,682",2.0,7.0,12.0,-5.0,INCY
1013,M,2010-09-23 17:39:05,2010-09-21,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",S - Sale,$14.88,-1016787,7511046,-12%,"-$15,126,583",2.0,7.0,12.0,-5.0,INCY
1014,M,2010-08-11 17:31:39,2010-08-09,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,-12803,271646,-5%,"-$180,074",-1.0,-1.0,4.0,13.0,INCY
1015,M,2010-08-11 17:24:56,2010-08-09,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,-8547,181362,-5%,"-$120,214",-1.0,-1.0,4.0,13.0,INCY
1016,M,2010-08-11 17:22:56,2010-08-09,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,-156929,3330071,-5%,"-$2,207,205",-1.0,-1.0,4.0,13.0,INCY
1017,M,2010-08-11 17:21:05,2010-08-09,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,-401872,8527833,-5%,"-$5,652,328",-1.0,-1.0,4.0,13.0,INCY
1018,M,2010-08-11 17:18:57,2010-08-09,INCY,"14159 Capital (Gp), LLC","Dir, 10%",S - Sale,$14.07,-12705,269649,-4%,"-$178,696",-1.0,-1.0,4.0,13.0,INCY
1019,D,2010-08-10 16:09:21,2010-08-06,INCY,Schreck Patricia A,"EVP, GC",M - OptEx,$6.15,94960,4500,-105%,"+$584,004",-4.0,-5.0,0.0,8.0,INCY
1020,D,2010-08-10 16:09:21,2010-08-06,INCY,Schreck Patricia A,"EVP, GC",S - Sale+OE,$13.88,-94960,4500,-95%,"-$1,318,250",-4.0,-5.0,0.0,8.0,INCY
1021,,2010-08-10 16:08:44,2010-08-09,INCY,Chardonnet Laurent,Vice President and Treasurer,S - Sale,$14.06,-15618,5343,-75%,"-$219,535",-4.0,-5.0,0.0,8.0,INCY
1022,D,2010-07-08 16:08:44,2010-07-07,INCY,Friedman Paul A,CEO,M - OptEx,$6.17,25142,289707,+10%,"+$155,034",4.0,7.0,19.0,44.0,INCY
1023,,2010-07-06 07:51:08,2010-07-01,INCY,Hastings David C,CFO,P - Purchase,$10.24,2000,8500,+31%,"+$20,480",0.0,9.0,25.0,54.0,INCY
1024,,2010-07-06 07:50:53,2010-07-01,INCY,Friedman Paul A,CEO,P - Purchase,$10.43,10000,264565,+4%,"+$104,257",0.0,9.0,25.0,54.0,INCY
1025,D,2010-06-21 16:10:33,2010-06-17,INCY,Swain Paula J,"EVP, HR",M - OptEx,$6.05,97917,0,-100%,"+$592,064",-7.0,-5.0,-6.0,19.0,INCY
1026,D,2010-06-21 16:10:33,2010-06-17,INCY,Swain Paula J,"EVP, HR",S - Sale+OE,$13.15,-97917,0,-100%,"-$1,287,609",-7.0,-5.0,-6.0,19.0,INCY
1027,D,2010-03-17 16:41:52,2010-03-15,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",M - OptEx,$4.19,20000,0,-100%,"+$83,800",-2.0,6.0,6.0,4.0,INCY
1028,D,2010-03-17 16:41:52,2010-03-15,INCY,Levy Richard S,"EVP, Chief Drug Dev, Medical O",S - Sale+OE,$12.94,-20000,0,-100%,"-$258,800",-2.0,6.0,6.0,4.0,INCY
1029,,2010-01-08 16:29:36,2010-01-08,INCY,Friedman Steven M.,"EVP, Biology, Preclinical Dev",S - Sale,$10.90,-22000,38137,-37%,"-$239,800",1.0,-7.0,-9.0,10.0,INCY
1030,D,2009-09-28 21:14:18,2009-09-24,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",A - Grant,$6.75,1848200,8929705,+26%,"+$12,475,350",-1.0,-2.0,-20.0,110.0,INCY
1031,D,2009-09-28 20:48:59,2009-09-24,INCY,"14159 Capital (Gp), LLC","Dir, 10%",A - Grant,$6.75,101506,282354,+56%,"+$685,166",-1.0,-2.0,-20.0,110.0,INCY
1032,D,2009-09-28 20:45:09,2009-09-24,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",A - Grant,$6.75,50294,189909,+36%,"+$339,485",-1.0,-2.0,-20.0,110.0,INCY
1033,M,2009-03-10 16:33:24,2009-03-06,INCY,Friedman Paul A,CEO,P - Purchase,$2.10,20000,254565,+9%,"+$42,000",-8.0,-3.0,-2.0,228.0,INCY
1034,DM,2009-03-05 18:16:06,2009-03-03,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,162,139615,0%,+$348,0.0,-3.0,10.0,178.0,INCY
1035,DM,2009-03-05 18:03:28,2009-03-03,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,3447,3487000,0%,"+$7,402",0.0,-3.0,10.0,178.0,INCY
1036,DM,2009-03-05 17:51:29,2009-03-03,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,10,284449,0%,+$21,0.0,-3.0,10.0,178.0,INCY
1037,DM,2009-03-05 17:31:53,2009-03-03,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,20756,7081505,0%,"+$44,630",0.0,-3.0,10.0,178.0,INCY
1038,DM,2009-03-05 17:19:24,2009-03-03,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,576,180848,0%,"+$1,239",0.0,-3.0,10.0,178.0,INCY
1039,M,2009-03-05 16:41:12,2009-03-03,INCY,Friedman Paul A,CEO,P - Purchase,$2.20,20000,234565,+9%,"+$44,000",0.0,-3.0,10.0,178.0,INCY
1040,D,2009-03-02 20:05:46,2009-03-02,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,17,284439,0%,+$37,-3.0,-6.0,-2.0,179.0,INCY
1041,D,2009-03-02 19:34:02,2009-03-02,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,343,139453,0%,+$738,-3.0,-6.0,-2.0,179.0,INCY
1042,D,2009-03-02 18:40:28,2009-03-02,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,7701,3483553,0%,"+$16,580",-3.0,-6.0,-2.0,179.0,INCY
1043,AD,2009-03-02 18:24:00,2009-03-02,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,927,180272,+1%,"+$1,996",-3.0,-6.0,-2.0,179.0,INCY
1044,AD,2009-03-02 18:07:14,2009-03-02,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,33364,7060749,0%,"+$71,831",-3.0,-6.0,-2.0,179.0,INCY
1045,D,2009-03-02 16:49:11,2009-03-02,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,927,180272,+1%,"+$1,996",-3.0,-6.0,-2.0,179.0,INCY
1046,D,2009-03-02 16:40:30,2009-03-02,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$2.15,33364,7060749,0%,"+$71,831",-3.0,-6.0,-2.0,179.0,INCY
1047,ADM,2008-12-22 20:50:34,2008-12-17,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.50,227282,3475852,+7%,"+$796,590",-1.0,-7.0,-14.0,-8.0,INCY
1048,ADM,2008-12-22 20:48:02,2008-12-17,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.49,839,284422,0%,"+$2,930",-1.0,-7.0,-14.0,-8.0,INCY
1049,ADM,2008-12-22 20:47:09,2008-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,20088,344663,+6%,"+$70,422",-1.0,-7.0,-14.0,-8.0,INCY
1050,ADM,2008-12-22 20:46:03,2008-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,735417,7027385,+12%,"+$2,578,159",-1.0,-7.0,-14.0,-8.0,INCY
1051,ADM,2008-12-22 20:38:42,2008-12-17,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,5056,139110,+4%,"+$17,730",-1.0,-7.0,-14.0,-8.0,INCY
1052,DM,2008-12-19 19:24:26,2008-12-17,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.50,227270,3475840,+7%,"+$796,551",-5.0,-5.0,-10.0,-14.0,INCY
1053,DM,2008-12-19 19:12:17,2008-12-17,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.55,1896,285479,+1%,"+$6,734",-5.0,-5.0,-10.0,-14.0,INCY
1054,DM,2008-12-19 18:52:27,2008-12-17,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,5056,139110,+4%,"+$17,730",-5.0,-5.0,-10.0,-14.0,INCY
1055,ADM,2008-12-19 18:44:31,2008-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,20085,344660,+6%,"+$70,412",-5.0,-5.0,-10.0,-14.0,INCY
1056,ADM,2008-12-19 18:42:56,2008-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,735332,7027300,+12%,"+$2,577,883",-5.0,-5.0,-10.0,-14.0,INCY
1057,DM,2008-12-19 18:38:25,2008-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,735332,7027300,+12%,"+$2,577,883",-5.0,-5.0,-10.0,-14.0,INCY
1058,DM,2008-12-19 18:08:56,2008-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$3.51,20085,344660,+6%,"+$70,412",-5.0,-5.0,-10.0,-14.0,INCY
1059,,2008-11-24 07:53:15,2008-11-21,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,P - Purchase,$2.19,5000,49839,+11%,"+$10,950",4.0,4.0,23.0,5.0,INCY
1060,,2008-11-21 08:03:08,2008-11-20,INCY,Chardonnet Laurent,Vice President and Treasurer,P - Purchase,$2.71,8000,8250,>999%,"+$21,677",13.0,34.0,41.0,18.0,INCY
1061,,2008-11-21 08:02:53,2008-11-20,INCY,Hastings David C,CFO,P - Purchase,$2.36,4000,6500,+160%,"+$9,440",13.0,34.0,41.0,18.0,INCY
1062,,2008-11-21 08:02:39,2008-11-20,INCY,Schreck Patricia A,"EVP, GC",P - Purchase,$2.44,2500,4500,+125%,"+$6,100",13.0,34.0,41.0,18.0,INCY
1063,,2008-11-21 08:02:24,2008-11-20,INCY,Friedman Paul A,CEO,P - Purchase,$2.55,13000,214565,+6%,"+$33,147",13.0,34.0,41.0,18.0,INCY
1064,M,2008-10-16 16:28:21,2008-10-14,INCY,Friedman Paul A,CEO,P - Purchase,$4.95,10000,201565,+5%,"+$49,506",-2.0,9.0,-19.0,-63.0,INCY
1065,,2008-08-05 09:29:36,2008-07-31,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,201648,3248570,+7%,"+$1,814,832",0.0,2.0,1.0,-67.0,INCY
1066,,2008-08-05 09:17:37,2008-07-31,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,1539,283583,+1%,"+$13,851",0.0,2.0,1.0,-67.0,INCY
1067,,2008-08-05 09:16:02,2008-07-31,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,864092,6291968,+16%,"+$7,776,828",0.0,2.0,1.0,-67.0,INCY
1068,,2008-08-05 09:15:06,2008-07-31,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,27724,159257,+21%,"+$249,516",0.0,2.0,1.0,-67.0,INCY
1069,,2008-08-05 09:09:41,2008-07-31,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.00,4997,134054,+4%,"+$44,973",0.0,2.0,1.0,-67.0,INCY
1070,,2008-01-24 17:04:12,2008-01-22,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,7,131533,0%,+$74,-2.0,5.0,-14.0,-21.0,INCY
1071,,2008-01-24 17:03:13,2008-01-22,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,223,5427876,0%,"+$2,368",-2.0,5.0,-14.0,-21.0,INCY
1072,,2008-01-24 17:01:45,2008-01-22,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,65,3046922,0%,+$690,-2.0,5.0,-14.0,-21.0,INCY
1073,,2008-01-24 17:00:43,2008-01-22,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,4,129057,0%,+$42,-2.0,5.0,-14.0,-21.0,INCY
1074,,2008-01-24 16:59:48,2008-01-22,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.62,1,282044,0%,+$11,-2.0,5.0,-14.0,-21.0,INCY
1075,,2008-01-16 16:46:39,2008-01-14,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,94,282043,0%,"+$1,033",4.0,1.0,8.0,-22.0,INCY
1076,,2008-01-16 16:45:39,2008-01-14,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,34621,5427653,+1%,"+$380,398",4.0,1.0,8.0,-22.0,INCY
1077,,2008-01-16 16:44:39,2008-01-14,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,1101,131526,+1%,"+$12,097",4.0,1.0,8.0,-22.0,INCY
1078,,2008-01-16 16:43:46,2008-01-14,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,13675,3046857,0%,"+$150,254",4.0,1.0,8.0,-22.0,INCY
1079,,2008-01-16 16:42:10,2008-01-14,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.99,723,129053,+1%,"+$7,944",4.0,1.0,8.0,-22.0,INCY
1080,M,2008-01-11 16:46:47,2008-01-09,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,334,281949,0%,"+$3,655",5.0,10.0,7.0,-24.0,INCY
1081,M,2008-01-11 16:44:17,2008-01-09,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,48393,3033182,+2%,"+$529,507",5.0,10.0,7.0,-24.0,INCY
1082,M,2008-01-11 16:43:20,2008-01-09,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,122514,5393032,+2%,"+$1,340,524",5.0,10.0,7.0,-24.0,INCY
1083,M,2008-01-11 16:41:47,2008-01-09,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,3891,259877,+2%,"+$42,575",5.0,10.0,7.0,-24.0,INCY
1084,M,2008-01-11 16:39:47,2008-01-09,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.94,2559,128330,+2%,"+$28,000",5.0,10.0,7.0,-24.0,INCY
1085,M,2008-01-08 17:39:03,2008-01-04,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,993832,5270518,+23%,"+$10,078,734",-3.0,0.0,1.0,-40.0,INCY
1086,M,2008-01-08 17:35:03,2008-01-04,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,31573,252300,+14%,"+$320,189",-3.0,0.0,1.0,-40.0,INCY
1087,M,2008-01-08 17:32:33,2008-01-04,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,392571,2984789,+15%,"+$3,981,175",-3.0,0.0,1.0,-40.0,INCY
1088,M,2008-01-08 17:28:09,2008-01-04,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,20749,125771,+20%,"+$210,422",-3.0,0.0,1.0,-40.0,INCY
1089,M,2008-01-08 17:22:05,2008-01-04,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.14,2712,281615,+1%,"+$27,504",-3.0,0.0,1.0,-40.0,INCY
1090,M,2007-12-19 17:44:49,2007-12-17,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,4960,105022,+5%,"+$52,563",1.0,-1.0,7.0,-18.0,INCY
1091,M,2007-12-19 17:41:53,2007-12-17,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,648,278903,0%,"+$6,867",1.0,-1.0,7.0,-18.0,INCY
1092,M,2007-12-19 17:39:18,2007-12-17,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,93849,2592218,+4%,"+$994,552",1.0,-1.0,7.0,-18.0,INCY
1093,M,2007-12-19 17:33:53,2007-12-17,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,237587,4276686,+6%,"+$2,517,796",1.0,-1.0,7.0,-18.0,INCY
1094,M,2007-12-19 17:30:49,2007-12-17,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$10.60,7549,187088,+4%,"+$80,000",1.0,-1.0,7.0,-18.0,INCY
1095,,2007-12-13 16:18:25,2007-11-27,INCY,Whitfield Roy A,Dir,G - Gift,$0.00,-3654,971335,0%,-$0,-3.0,-1.0,6.0,-22.0,INCY
1096,M,2007-12-12 17:11:41,2007-12-10,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,433415,4039099,+12%,"+$4,329,179",3.0,2.0,4.0,-19.0,INCY
1097,M,2007-12-12 17:08:37,2007-12-10,INCY,"14159 Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,13769,169406,+9%,"+$137,533",3.0,2.0,4.0,-19.0,INCY
1098,M,2007-12-12 17:07:12,2007-12-10,INCY,"Baker Bros. Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,1183,278255,0%,"+$11,816",3.0,2.0,4.0,-19.0,INCY
1099,AM,2007-12-12 16:56:41,2007-12-10,INCY,"Baker / Tisch Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,9049,100062,+10%,"+$90,386",3.0,2.0,4.0,-19.0,INCY
1100,AM,2007-12-12 16:54:37,2007-12-10,INCY,"Baker Biotech Capital (Gp), LLC","Dir, 10%",P - Purchase,$9.99,171202,2498369,+7%,"+$1,710,056",3.0,2.0,4.0,-19.0,INCY
1101,M,2007-12-12 16:45:08,2007-12-10,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$9.99,171202,2498369,+7%,"+$1,710,056",3.0,2.0,4.0,-19.0,INCY
1102,M,2007-12-12 16:38:43,2007-12-10,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$9.99,9049,100062,+10%,"+$90,386",3.0,2.0,4.0,-19.0,INCY
1103,,2007-12-06 17:12:02,2007-12-04,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.98,1139,91013,+1%,"+$10,230",-5.0,8.0,-3.0,-13.0,INCY
1104,,2007-12-06 17:10:07,2007-12-04,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.98,19593,2327167,+1%,"+$175,980",-5.0,8.0,-3.0,-13.0,INCY
1105,,2007-12-06 17:09:03,2007-12-04,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.98,1812,73643,+3%,"+$16,275",-5.0,8.0,-3.0,-13.0,INCY
1106,,2007-12-06 17:07:37,2007-12-04,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.98,57303,3605684,+2%,"+$514,684",-5.0,8.0,-3.0,-13.0,INCY
1107,,2007-12-06 17:06:33,2007-12-04,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.98,153,277072,0%,"+$1,374",-5.0,8.0,-3.0,-13.0,INCY
1108,M,2007-12-03 18:56:30,2007-11-29,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.68,17130,2307574,+1%,"+$148,697",5.0,2.0,12.0,-8.0,INCY
1109,M,2007-12-03 18:51:30,2007-11-29,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.68,3043,71831,+4%,"+$26,415",5.0,2.0,12.0,-8.0,INCY
1110,M,2007-12-03 18:47:00,2007-11-29,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.68,96313,3548381,+3%,"+$836,043",5.0,2.0,12.0,-8.0,INCY
1111,M,2007-12-03 18:40:31,2007-11-29,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.68,258,276919,0%,"+$2,240",5.0,2.0,12.0,-8.0,INCY
1112,M,2007-11-28 17:31:01,2007-11-26,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.11,1102,276661,0%,"+$8,936",2.0,12.0,22.0,18.0,INCY
1113,M,2007-11-28 17:24:02,2007-11-26,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.11,73260,2290444,+3%,"+$594,060",2.0,12.0,22.0,18.0,INCY
1114,M,2007-11-28 17:19:32,2007-11-26,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.11,411940,3452068,+14%,"+$3,340,392",2.0,12.0,22.0,18.0,INCY
1115,M,2007-11-28 17:14:29,2007-11-26,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.11,13019,68788,+23%,"+$105,570",2.0,12.0,22.0,18.0,INCY
1116,M,2007-11-21 17:05:20,2007-11-19,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.18,70742,2217184,+3%,"+$579,009",1.0,4.0,32.0,22.0,INCY
1117,M,2007-11-21 17:04:24,2007-11-19,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.17,278911,3040128,+10%,"+$2,278,239",1.0,4.0,32.0,22.0,INCY
1118,M,2007-11-21 16:58:24,2007-11-19,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.17,8814,55769,+19%,"+$71,996",1.0,4.0,32.0,22.0,INCY
1119,M,2007-11-21 16:55:51,2007-11-19,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.17,747,275559,0%,"+$6,102",1.0,4.0,32.0,22.0,INCY
1120,,2007-11-21 16:52:50,2007-11-19,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.22,318,89874,0%,"+$2,615",1.0,4.0,32.0,22.0,INCY
1121,M,2007-11-16 17:41:21,2007-11-14,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.49,10664,46955,+29%,"+$90,538",-3.0,-2.0,26.0,23.0,INCY
1122,M,2007-11-16 17:40:23,2007-11-14,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.49,337456,2761217,+14%,"+$2,865,032",-3.0,-2.0,26.0,23.0,INCY
1123,M,2007-11-16 17:39:21,2007-11-14,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.50,126099,2146442,+6%,"+$1,071,955",-3.0,-2.0,26.0,23.0,INCY
1124,M,2007-11-16 17:38:26,2007-11-14,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.49,904,274812,0%,"+$7,675",-3.0,-2.0,26.0,23.0,INCY
1125,AM,2007-11-16 16:24:18,2007-11-14,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.51,1053,89556,+1%,"+$8,965",-3.0,-2.0,26.0,23.0,INCY
1126,D,2007-11-15 16:31:02,2007-11-13,INCY,De Schutter Richard U,Chairman,M - OptEx,$4.27,70000,95000,+280%,"+$299,200",-3.0,-5.0,23.0,20.0,INCY
1127,M,2007-11-13 17:45:21,2007-11-09,INCY,"Baker / Tisch Capital (Gp), LLC",Dir,P - Purchase,$8.09,2442,88503,+3%,"+$19,746",2.0,-3.0,25.0,22.0,INCY
1128,M,2007-11-13 17:42:15,2007-11-09,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$8.09,21926,36291,+153%,"+$177,292",2.0,-3.0,25.0,22.0,INCY
1129,M,2007-11-13 17:40:26,2007-11-09,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$8.09,274182,3998325,+7%,"+$2,217,012",2.0,-3.0,25.0,22.0,INCY
1130,M,2007-11-13 17:38:16,2007-11-09,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$8.09,693773,2423761,+40%,"+$5,609,789",2.0,-3.0,25.0,22.0,INCY
1131,M,2007-11-13 17:35:50,2007-11-09,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$8.09,1857,273908,+1%,"+$15,016",2.0,-3.0,25.0,22.0,INCY
1132,,2007-08-20 16:10:07,2007-08-17,INCY,Friedman Paul A,CEO,P - Purchase,$5.47,16665,191565,+10%,"+$91,159",5.0,5.0,16.0,116.0,INCY
1133,M,2007-08-03 17:36:54,2007-08-01,INCY,"Baker Biotech Capital (Gp), LLC",Dir,P - Purchase,$4.91,171332,1746161,+11%,"+$840,554",11.0,5.0,21.0,151.0,INCY
1134,M,2007-08-03 17:35:49,2007-08-01,INCY,"Baker Brothers Life Sciences Capital (Gp), LLC",Dir,P - Purchase,$4.91,451861,1729988,+35%,"+$2,216,827",11.0,5.0,21.0,151.0,INCY
1135,M,2007-08-03 17:34:53,2007-08-01,INCY,"Baker Bros. Capital (Gp), LLC",Dir,P - Purchase,$4.91,1151,272051,0%,"+$5,647",11.0,5.0,21.0,151.0,INCY
1136,M,2007-08-03 17:33:50,2007-08-01,INCY,"14159 Capital (Gp), LLC",Dir,P - Purchase,$4.91,14365,14365,New,"+$70,475",11.0,5.0,21.0,151.0,INCY
1137,D,2007-02-13 19:01:00,2006-04-17,INCY,Metcalf Brian W,Chief Drug Discovery Scientist,P - Purchase,$3.88,5000,32906,+18%,"+$19,416",0.0,-2.0,-13.0,-30.0,INCY
1138,,2007-01-03 16:46:14,2006-12-21,INCY,Whitfield Roy A,Dir,G - Gift,$0.00,-1800,974989,0%,-$0,3.0,18.0,24.0,1.0,INCY
1139,,2006-04-07 08:23:09,2006-04-06,INCY,Swain Paula J,"EVP, HR",P - Purchase,$3.65,3000,18061,+20%,"+$10,950",2.0,4.0,14.0,16.0,INCY
1140,,2006-04-05 08:25:53,2006-04-04,INCY,Friedman Paul A,CEO,P - Purchase,$3.56,5500,174900,+3%,"+$19,580",6.0,3.0,17.0,15.0,INCY
1141,,2006-04-05 08:25:34,2006-04-04,INCY,Hastings David C,CFO,P - Purchase,$3.60,2500,2500,New,"+$9,000",6.0,3.0,17.0,15.0,INCY
1142,,2006-04-05 08:25:21,2006-04-04,INCY,Schreck Patricia A,"EVP, GC",P - Purchase,$3.59,2000,2000,New,"+$7,180",6.0,3.0,17.0,15.0,INCY
1143,,2006-01-04 17:18:53,2005-12-22,INCY,Whitfield Roy A,Dir,G - Gift,$0.00,-4300,976789,0%,-$0,1.0,4.0,2.0,-14.0,INCY
1144,D,2005-12-15 17:00:19,2005-11-26,INCY,Friedman Paul A,CEO,M - OptEx,$0.00,50000,169400,+42%,+$0,-3.0,-3.0,-11.0,-33.0,INCY
1145,,2005-08-23 15:20:16,2005-08-23,INCY,Friedman Paul A,CEO,P - Purchase,$7.24,2700,119400,+2%,"+$19,559",0.0,5.0,2.0,-22.0,INCY
1146,D,2005-03-11 18:17:20,2005-03-10,INCY,Whitfield Roy A,Dir,F - Tax,$7.24,-18737,983389,-2%,"-$135,656",1.0,-4.0,-9.0,4.0,INCY
1147,D,2005-03-11 18:17:20,2005-03-10,INCY,Whitfield Roy A,Dir,M - OptEx,$0.00,50000,983389,+5%,+$0,1.0,-4.0,-9.0,4.0,INCY
1148,,2005-03-10 15:27:28,2005-03-09,INCY,De Schutter Richard U,Dir,P - Purchase,$7.05,20000,25000,+400%,"+$140,950",0.0,1.0,-5.0,8.0,INCY
1149,D,2005-03-10 14:17:59,2005-03-10,INCY,Friedman Paul A,CEO,M - OptEx,$0.00,50000,116700,+75%,+$0,0.0,1.0,-5.0,8.0,INCY
1150,,2004-11-04 16:08:55,2004-11-01,INCY,Baker Julian,Dir,P - Purchase,$9.75,300000,209948,-333%,"+$2,925,000",6.0,12.0,20.0,-11.0,INCY
1151,,2004-09-13 18:33:35,2004-09-09,INCY,Brooke Paul A,Dir,P - Purchase,$7.74,100000,149584,+202%,"+$774,000",3.0,2.0,22.0,-10.0,INCY
1152,,2004-08-17 16:34:54,2004-08-16,INCY,Friedman Paul A,CEO,P - Purchase,$5.62,3500,421135,+1%,"+$19,658",6.0,8.0,50.0,48.0,INCY
1153,A,2004-08-13 15:58:35,2004-08-12,INCY,Tisch Thomas J,No longer 10% owner.,P - Purchase,$5.50,255750,1534253,+20%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1154,A,2004-08-13 15:58:06,2004-08-12,INCY,Tisch James S,No longer 10% owner.,P - Purchase,$5.50,255750,1334253,+24%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1155,A,2004-08-13 15:57:37,2004-08-12,INCY,Tisch Andrew H,No longer 10% owner.,P - Purchase,$5.50,255750,1334253,+24%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1156,A,2004-08-13 15:57:05,2004-08-12,INCY,Tisch Daniel R,No longer 10% owner.,P - Purchase,$5.50,255750,1334253,+24%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1157,,2004-08-13 13:23:28,2004-08-12,INCY,Tisch Daniel R,10%,P - Purchase,$5.50,255750,1334253,+24%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1158,,2004-08-13 13:22:36,2004-08-12,INCY,Tisch Andrew H,10%,P - Purchase,$5.50,255750,1334253,+24%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1159,,2004-08-13 13:21:50,2004-08-12,INCY,Tisch James S,10%,P - Purchase,$5.50,255750,1334253,+24%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1160,,2004-08-13 13:20:59,2004-08-12,INCY,Tisch Thomas J,10%,P - Purchase,$5.50,255750,1534253,+20%,"+$1,406,625",1.0,15.0,55.0,56.0,INCY
1161,D,2004-04-01 14:08:05,2004-03-30,INCY,Saxe Jon S,Dir,M - OptEx,$2.78,20000,80000,+33%,"+$55,626",-1.0,1.0,-4.0,16.0,INCY
1162,,2003-09-24 17:22:50,2003-09-22,INCY,Baker Bros Capital Gp LLC,10%,P - Purchase,$4.97,13800,526800,+3%,"+$68,592",-8.0,-12.0,1.0,48.0,INCY
1163,,2003-09-24 17:22:37,2003-09-22,INCY,Baker Biotech Capital II Gp LLC,10%,P - Purchase,$4.97,71100,2181814,+3%,"+$353,399",-8.0,-12.0,1.0,48.0,INCY
1164,,2003-09-24 17:22:26,2003-09-22,INCY,Baker Biotech Capital Gp LLC,10%,P - Purchase,$4.97,67300,2959310,+2%,"+$334,507",-8.0,-12.0,1.0,48.0,INCY
1165,,2003-09-23 17:18:43,2003-09-19,INCY,Baker Bros Capital Gp LLC,10%,P - Purchase,$5.04,107650,249700,+76%,"+$542,276",6.0,-3.0,10.0,60.0,INCY
1166,,2003-09-23 17:18:30,2003-09-19,INCY,Baker Biotech Capital Gp LLC,10%,P - Purchase,$5.04,526000,1412855,+59%,"+$2,649,672",6.0,-3.0,10.0,60.0,INCY
1167,,2003-09-23 17:18:15,2003-09-19,INCY,Baker Biotech Capital II Gp LLC,10%,P - Purchase,$5.04,556350,1020307,+120%,"+$2,802,557",6.0,-3.0,10.0,60.0,INCY
